Microbiology Thesis Topics For MD/DNB Microbiology
This collection of basic and general microbiology thesis topics is intended for MD and DNB Microbiology candidates exploring bacterial structure and physiology, microbial genetics, identification methods, antimicrobial resistance and laboratory quality. These basic and general microbiology research topics can be shaped into projects completable within one thesis period using routinely received patient specimens, available isolates and investigations already established in the department, with advanced assays selected only where access and funding are confirmed. Each selected question should be developed into a basic and general microbiology protocol and an institution-specific basic and general microbiology synopsis.
Last reviewed and updated: September 2026 · 2026–27 admissions
General Bacteriology
Bacterial Structure and Physiology
Comparative assessment of Gram-stain morphology and colony characteristics against conventional biochemical identification in consecutive bacterial isolates from clinical specimens, with identification concordance assessed at forty-eight hours: a laboratory-based cross-sectional study.
Association of Gram-stain cell morphology with species distribution among consecutive bacterial isolates from urine, pus, and respiratory specimens, with final identification determined by routine culture: a laboratory-based cross-sectional study.
Comparative evaluation of cell-wall related Gram-stain characteristics against conventional culture identification among common Gram-positive and Gram-negative clinical isolates, with categorical agreement measured at final reporting: a method-comparison study.
Association of mucoid colony morphology with antimicrobial resistance among Klebsiella pneumoniae isolates from urine and respiratory specimens, with resistance proportions determined at final susceptibility reporting: an analytical cross-sectional study.
Association of pigment production with antimicrobial susceptibility patterns among Pseudomonas aeruginosa isolates from pus, urine, and respiratory specimens, with resistance profiles assessed at final reporting: a laboratory-based cross-sectional study.
Comparative characterization of lactose fermentation on MacConkey agar against biochemical identification among Enterobacterales from urine cultures, with species-level concordance measured after forty-eight hours: a laboratory-based method-comparison study.
Diagnostic accuracy of swarming growth on blood agar against conventional biochemical identification for recognition of Proteus species from urine cultures, with sensitivity and specificity measured at forty-eight hours.
Association of colony haemolysis on blood agar with antimicrobial resistance among Staphylococcus aureus isolates from pus and wound specimens, with susceptibility outcomes assessed at final laboratory reporting: an analytical cross-sectional study.
Comparative evaluation of colony morphology at eighteen and twenty-four hours against final biochemical identification among common urinary pathogens, with identification accuracy and turnaround time measured prospectively.
Association of bacterial growth rate in automated blood culture with organism group among monomicrobial bloodstream isolates, with time to positivity and final identification compared during the same admission: a retrospective study.
Correlation of automated blood culture time to positivity with bacterial morphology on direct Gram staining among positive blood culture bottles, with associations assessed at final species identification: a laboratory-based observational study.
Association of time to positivity with antimicrobial resistance among Escherichia coli bloodstream isolates, with susceptibility categories determined by routine testing during the same bacteremic episode: a retrospective analytical study.
Association of time to positivity with antimicrobial resistance among Klebsiella pneumoniae bloodstream isolates, with susceptibility categories determined at final reporting during the same hospital admission: a retrospective analytical study.
Association of time to positivity with clinical outcome among adults with Staphylococcus aureus bloodstream infection, with mortality and discharge status assessed during the index admission: a retrospective observational study.
Association of bacterial colony density on semiquantitative urine culture with pyuria among symptomatic adults, using significant bacteriuria by routine culture as reference and outcomes assessed at forty-eight hours.
Correlation of quantitative pyuria with bacterial colony counts among adults with culture-confirmed urinary tract infection, with microscopy and culture results compared during the same clinical episode: a cross-sectional study.
Comparative evaluation of calibrated loop inoculation volumes for semiquantitative urine culture against standard laboratory inoculation, with colony-count agreement measured after overnight incubation: a laboratory-based method-comparison study.
Association of urine storage duration before culture with colony counts in routine midstream specimens, with culture positivity and contamination assessed at forty-eight hours: a prospective observational study.
Association of specimen transport delay with bacterial recovery from pus and wound swabs, using routinely processed specimens as comparator and pathogen yield assessed at forty-eight hours.
Comparative evaluation of immediate and delayed processing of surplus urine specimens for recovery of common uropathogens, with colony-count differences measured after overnight incubation: a laboratory-based observational study.
Association of sputum quality scores on direct microscopy with bacterial culture yield among adult respiratory specimens, with significant pathogen recovery assessed at forty-eight hours: a diagnostic cross-sectional study.
Diagnostic accuracy of direct sputum microscopy quality criteria against culture contamination among adult respiratory samples, with sensitivity and specificity measured at final culture reporting.
Association of bacterial morphotypes seen on direct sputum Gram staining with subsequent culture identification among acceptable-quality respiratory specimens, with concordance measured at forty-eight hours: a cross-sectional study.
Comparative evaluation of blood agar and chocolate agar for recovery of respiratory bacterial pathogens from acceptable sputum specimens, with incremental yield assessed at forty-eight hours: a laboratory-based comparative study.
Association of bacterial load estimated on direct microscopy with semiquantitative growth from pus specimens, with correlation assessed at final culture reporting: a laboratory-based analytical cross-sectional study.
Comparative assessment of aerobic growth characteristics of Escherichia coli from urine and bloodstream isolates, with colony size and biochemical reaction profiles measured after twenty-four hours: a laboratory-based cross-sectional study.
Comparative assessment of growth characteristics of Klebsiella pneumoniae from urine and respiratory isolates, with colony morphology and biochemical reactions measured after twenty-four hours: a laboratory-based cross-sectional study.
Association of mucoid phenotype with biofilm production among Klebsiella pneumoniae clinical isolates, using microtitre plate biofilm assay as comparator and biofilm strength assessed after incubation: an analytical cross-sectional study.
Association of colony pigmentation with biofilm formation among Pseudomonas aeruginosa clinical isolates, using microtitre plate assay and measuring biofilm categories after twenty-four hours: a laboratory-based analytical study.
Association of haemolytic phenotype with biofilm production among Staphylococcus aureus isolates from wound infections, using microtitre plate assay and assessing biofilm strength after incubation: an analytical cross-sectional study.
Comparative evaluation of aerobic and reduced-oxygen incubation for recovery of clinically significant bacteria from selected wound specimens, with incremental culture yield assessed at forty-eight hours: a laboratory-based observational study.
Association of prolonged incubation beyond routine overnight culture with additional bacterial recovery from sterile body fluids, with incremental yield measured at final forty-eight-hour reporting: a retrospective laboratory study.
Comparative evaluation of direct inoculation into blood culture bottles and conventional plating of sterile body fluids, with pathogen recovery and time to detection measured during routine processing.
Association of blood culture bottle fill volume with positivity among adult inpatient samples, using manufacturer-recommended volume as comparator and culture yield assessed during the index episode: a prospective observational study.
Association of blood culture bottle fill volume with contamination frequency among adult inpatient samples, using recommended fill volume as comparator and contamination assessed at final clinical classification.
Comparative evaluation of paired and single blood culture sets among adults investigated for bloodstream infection, with incremental pathogen recovery assessed during the same febrile episode: a prospective observational study.
Association of blood culture transport delay with time to positivity among adult inpatients, with final organism identification and culture yield assessed during the same admission: a prospective study.
Comparative evaluation of manual inspection and automated detection of visible microbial growth in positive culture bottles, with agreement and time-to-detection differences measured during routine laboratory processing.
Correlation of culture turbidity with viable bacterial growth among common Enterobacterales isolates in routine broth media, with semiquantitative growth assessed after overnight incubation: a laboratory-based observational study.
Comparative evaluation of bacterial growth on routinely prepared and commercially prepared culture media using common clinical isolates, with recovery and colony characteristics assessed after twenty-four hours.
Association of repeated subculture with changes in colony morphology among stored clinical isolates of common Enterobacterales, with phenotypic stability assessed after defined laboratory passages: an observational study.
Comparative evaluation of room-temperature and refrigerated short-term storage of surplus urine specimens, using immediate culture as reference and colony-count agreement measured within twenty-four hours.
Association of storage temperature with recovery of common urinary pathogens from surplus positive urine specimens, with viable colony counts assessed after predefined short storage intervals.
Comparative evaluation of inoculum preparation from direct colonies and standardized suspension among common bacterial isolates, with subsequent growth consistency assessed after overnight incubation: a laboratory-based method study.
Association of biofilm-forming capacity with growth characteristics among Staphylococcus aureus, Klebsiella pneumoniae, and Pseudomonas aeruginosa clinical isolates, with biofilm quantified after twenty-four hours: a cross-sectional study.
Bacterial Genetics
Association of plasmid-mediated phenotypic resistance patterns with multidrug resistance among Escherichia coli urinary isolates, using routine susceptibility profiles as markers and outcomes assessed at final reporting: an analytical cross-sectional study.
Association of transferable resistance phenotype with multidrug resistance among Klebsiella pneumoniae isolates, using phenotypic beta-lactamase tests and routine susceptibility profiles assessed during the same laboratory episode.
Correlation of extended spectrum beta lactamase phenotype with multidrug resistance among Escherichia coli and Klebsiella pneumoniae isolates, with resistance categories measured at final susceptibility reporting: a cross-sectional study.
Association of AmpC beta lactamase phenotype with multidrug resistance among cephalosporin-resistant Enterobacterales, using phenotypic confirmatory testing and assessing resistance patterns at final reporting.
Association of carbapenemase phenotype with multidrug resistance among carbapenem-resistant Klebsiella pneumoniae isolates, using phenotypic carbapenemase tests and routine susceptibility results assessed concurrently.
Correlation of inducible clindamycin resistance phenotype with erythromycin resistance among Staphylococcus aureus isolates, using disc approximation testing and final susceptibility categories measured after overnight incubation.
Association of methicillin resistance phenotype with multidrug resistance among Staphylococcus aureus clinical isolates, using cefoxitin disc diffusion as index test and routine susceptibility profile assessed at final reporting.
Association of vancomycin susceptibility patterns with multidrug resistance among Enterococcus faecalis and Enterococcus faecium clinical isolates, using broth microdilution and routine susceptibility results assessed concurrently.
Comparative phenotypic characterization of resistance combinations among Escherichia coli isolates from urine and bloodstream specimens, with multidrug resistance frequency assessed at final reporting: a laboratory-based cross-sectional study.
Comparative phenotypic characterization of resistance combinations among Klebsiella pneumoniae isolates from intensive care and general wards, with multidrug resistance frequency assessed at final reporting: a cross-sectional study.
Association of repeated antibiotic exposure documented in case records with multidrug-resistant Enterobacterales infection, using susceptible isolates as comparator and exposure assessed during the preceding ninety days.
Association of prior hospitalisation with multidrug-resistant Enterobacterales infection among adult inpatients, using susceptible Enterobacterales infections as comparator and prior exposure assessed over ninety days: a case-control study.
Association of invasive-device exposure with multidrug-resistant Gram-negative infection among inpatients, using susceptible infections as comparator and device exposure assessed before culture positivity: a case-control study.
Correlation of phenotypic beta-lactamase production with antimicrobial resistance combinations among Enterobacterales isolates, with resistance profiles determined by routine susceptibility testing at final reporting.
Association of cefoxitin resistance with presumptive AmpC beta lactamase production among Enterobacterales isolates, using phenotypic confirmatory testing as reference and accuracy assessed after overnight incubation.
Diagnostic accuracy of combined-disc phenotypic testing for extended spectrum beta lactamase against a routinely available molecular assay among selected Enterobacterales, with sensitivity and specificity measured after isolate characterization.
Agreement between phenotypic carbapenemase detection methods and routinely available polymerase chain reaction among carbapenem-resistant Enterobacterales, with concordance assessed after final laboratory characterization.
Association of resistance-gene carriage detected by routinely available polymerase chain reaction with phenotypic carbapenem resistance among Klebsiella pneumoniae isolates, with genotype-phenotype concordance assessed after testing.
Association of resistance-gene carriage with phenotypic extended spectrum beta lactamase production among Escherichia coli isolates, using conventional polymerase chain reaction and confirmatory phenotypic testing performed on stored isolates.
Correlation of selected virulence-gene carriage with biofilm formation among Escherichia coli urinary isolates, using routine polymerase chain reaction and microtitre plate assay with outcomes assessed after isolate characterization.
Correlation of selected virulence-gene carriage with biofilm formation among Klebsiella pneumoniae clinical isolates, using routine polymerase chain reaction and microtitre plate assay with outcomes assessed after testing.
Association of selected adhesin-gene carriage with recurrent urinary tract infection among Escherichia coli isolates, using routine polymerase chain reaction and case-record comparison over six months: an analytical study.
Association of selected toxin-gene carriage with clinical severity among culture-confirmed diarrhoeagenic Escherichia coli isolates, using routinely available polymerase chain reaction and discharge outcomes: a hospital-based observational study.
Comparative assessment of selected virulence-gene patterns among community- and hospital-acquired Staphylococcus aureus isolates, using routinely available polymerase chain reaction and clinical classification at admission.
Correlation of selected resistance genes with antimicrobial susceptibility phenotypes among Enterococcus species isolates, using routine polymerase chain reaction and broth microdilution with agreement assessed after isolate characterization.
Bacterial Pathogenesis
Association of biofilm formation with catheter-associated urinary tract infection among Escherichia coli isolates, using microtitre plate assay and non-catheter-associated urinary isolates as comparator: an analytical cross-sectional study.
Association of biofilm formation with catheter-associated urinary tract infection among Klebsiella pneumoniae isolates, using microtitre plate assay and non-catheter-associated urinary isolates as comparator.
Association of biofilm formation with device-associated bloodstream infection among coagulase-negative staphylococcal isolates, using microtitre plate assay and non-device bloodstream isolates as comparator: an analytical study.
Association of strong biofilm production with persistent bloodstream infection among Staphylococcus aureus isolates, using repeat culture status within seven days as clinical outcome: a prospective observational study.
Correlation of biofilm strength with antimicrobial resistance among Pseudomonas aeruginosa isolates from respiratory specimens, using microtitre plate assay and routine susceptibility testing performed concurrently.
Correlation of biofilm strength with antimicrobial resistance among Acinetobacter baumannii isolates from respiratory specimens, using microtitre plate assay and routine susceptibility testing performed concurrently.
Association of biofilm production with surgical site infection severity among Staphylococcus aureus isolates, using microtitre plate assay and wound classification documented during admission.
Association of biofilm production with prolonged hospitalisation among patients with Klebsiella pneumoniae infection, using microtitre plate assay and length of stay measured until discharge.
Comparative biofilm-forming capacity of Escherichia coli isolates from recurrent and first-episode urinary tract infection, with recurrence determined from six-month records and biofilm quantified by microtitre plate assay.
Comparative biofilm-forming capacity of Staphylococcus aureus isolates from implant-associated and non-implant wound infections, using microtitre plate assay and clinical classification during admission.
Association of alpha-haemolytic activity with clinical source among Staphylococcus aureus isolates, using blood agar phenotype and source categories determined at final culture reporting: a cross-sectional study.
Association of mucoid phenotype with invasive infection among Klebsiella pneumoniae isolates, using bloodstream isolates and non-bloodstream isolates as comparator with outcomes classified during admission.
Association of hypermucoviscous phenotype with antimicrobial resistance among Klebsiella pneumoniae clinical isolates, using string testing and routine susceptibility results assessed at final reporting: an analytical cross-sectional study.
Association of pigment production with invasive infection among Pseudomonas aeruginosa isolates, using bloodstream and non-bloodstream clinical isolates as comparator and final source classification.
Association of haemolysin production with urinary tract infection severity among Escherichia coli isolates, using routine phenotypic testing and admission status as clinical comparator: a cross-sectional study.
Association of adherence-associated biofilm phenotype with recurrent urinary tract infection among Escherichia coli isolates, using microtitre plate assay and six-month recurrence documented in records.
Association of coagulase phenotype intensity with bloodstream versus wound origin among Staphylococcus aureus isolates, using tube coagulase testing and final clinical source classification.
Association of extracellular enzyme production with chronic wound infection among Pseudomonas aeruginosa isolates, using routine phenotypic assays and acute wound isolates as comparator.
Association of bacterial biofilm phenotype with delayed wound healing among culture-positive surgical wounds, using microtitre plate assay and healing status assessed before discharge or thirty days.
Association of polymicrobial growth with adverse clinical outcomes among patients with culture-positive wound infection, using monomicrobial infections as comparator and discharge status as outcome.
Association of polymicrobial urinary culture with catheterisation among inpatients, using monomicrobial significant bacteriuria as comparator and device exposure assessed at specimen collection.
Association of bacterial load in quantitative urine culture with symptomatic disease among catheterized adults, using asymptomatic bacteriuria as comparator and clinical status determined at specimen collection.
Association of bloodstream infection source with time to positivity among Gram-negative bacilli, using automated blood culture and final clinical source classification during admission.
Association of shorter blood culture time to positivity with septic shock among adults with monomicrobial bacteraemia, using routine automated culture and clinical status documented within twenty-four hours.
Correlation of bacterial load estimated by blood culture time to positivity with inflammatory markers among adults with bloodstream infection, with laboratory values recorded within twenty-four hours.
Association of methicillin resistance with clinical outcome among patients with Staphylococcus aureus bloodstream infection, using cefoxitin disc diffusion and discharge mortality as outcome: a retrospective study.
Association of carbapenem resistance with clinical outcome among patients with Klebsiella pneumoniae bloodstream infection, using routine susceptibility testing and mortality assessed at discharge: a retrospective observational study.
Association of carbapenem resistance with prolonged hospitalisation among patients with Acinetobacter baumannii infection, using susceptible isolates as comparator and length of stay measured until discharge.
Correlation of bacterial virulence-associated phenotypes with multidrug resistance among common intensive-care Gram-negative isolates, using routine biochemical assays and susceptibility testing assessed during the same isolate characterization.
Association of invasive-device exposure with bloodstream infection caused by biofilm-producing organisms, using microtitre plate biofilm assay and non-device-associated cases as comparator during admission.
Bacterial Identification
Diagnostic accuracy of direct Gram staining against culture for detection of significant bacteriuria in symptomatic adults, with sensitivity and specificity assessed at forty-eight hours: a cross-sectional study.
Diagnostic accuracy of direct Gram staining against culture for prediction of bacterial category in positive blood culture bottles, with concordance measured at final species identification.
Agreement between two observers interpreting Gram-stained sputum smears against culture quality criteria, with inter-observer reliability and pathogen recovery assessed at forty-eight hours.
Diagnostic accuracy of sputum Gram-stain quality scoring against bacterial culture for clinically significant respiratory pathogens, with sensitivity and specificity assessed at final reporting.
Comparative evaluation of Gram staining from direct positive blood culture broth and colony growth, with morphological agreement assessed at final organism identification: a laboratory-based method-comparison study.
Diagnostic accuracy of direct microscopy of sterile body fluids against culture for bacterial infection, with sensitivity and specificity measured at final culture reporting: a laboratory-based cross-sectional study.
Comparative evaluation of conventional light microscopy and automated image-assisted Gram-stain interpretation where available, using culture identification as reference and agreement measured at final reporting.
Agreement between junior and senior microbiologists in Gram-stain interpretation of positive blood cultures, using final culture identification as reference and kappa assessed prospectively.
Diagnostic accuracy of direct Gram staining of pus specimens against culture for predominant bacterial morphology, with sensitivity and specificity measured after final identification.
Association of Gram-stain inflammatory cell counts with culture positivity among wound specimens, using final bacterial culture as reference and diagnostic performance assessed at forty-eight hours.
Comparative evaluation of colony morphology on blood agar and MacConkey agar against conventional biochemical identification among Enterobacterales, with identification concordance assessed after forty-eight hours.
Diagnostic accuracy of lactose fermentation on MacConkey agar for preliminary identification of common Enterobacterales, using biochemical identification as reference and accuracy measured after twenty-four hours.
Diagnostic accuracy of swarming motility for recognition of Proteus species from urine cultures, using biochemical identification as reference and performance assessed after overnight incubation.
Diagnostic accuracy of oxidase testing for preliminary differentiation of non-fermenting Gram-negative bacilli, using automated identification as reference and sensitivity and specificity measured the same day.
Agreement between slide and tube coagulase tests for identification of Staphylococcus aureus, using automated identification as reference and kappa measured after routine testing.
Diagnostic accuracy of mannitol fermentation for presumptive Staphylococcus aureus identification, using tube coagulase and automated identification as reference and performance measured after overnight incubation.
Comparative evaluation of catalase testing methods for differentiation of staphylococci and streptococci, using final routine identification as reference and agreement measured immediately.
Diagnostic accuracy of bile esculin hydrolysis for presumptive Enterococcus identification, using conventional biochemical identification as reference and performance assessed after twenty-four hours.
Diagnostic accuracy of pyrrolidonyl arylamidase testing for presumptive Enterococcus identification, using automated identification as reference and sensitivity and specificity assessed during routine processing.
Comparative evaluation of conventional biochemical identification and automated identification among Enterobacterales from routine clinical specimens, with species-level agreement and turnaround time measured at final reporting.
Comparative evaluation of conventional biochemical identification and automated identification among non-fermenting Gram-negative bacilli, with species-level agreement and turnaround time measured at final reporting.
Comparative evaluation of conventional biochemical identification and automated identification among Gram-positive cocci, with species-level agreement and turnaround time measured during routine laboratory processing.
Agreement between triple sugar iron agar reactions and automated identification for preliminary categorization of Enterobacterales, with discordance characterized after final species identification.
Diagnostic accuracy of indole testing for differentiation of selected Enterobacterales species, using automated identification as reference and sensitivity and specificity assessed after overnight incubation.
Diagnostic accuracy of citrate utilisation for preliminary differentiation of common Enterobacterales, using automated identification as reference and performance assessed after twenty-four hours.
Diagnostic accuracy of urease testing for identification of Proteus, Morganella, and Providencia species, using automated identification as reference and performance assessed after routine incubation.
Comparative evaluation of motility testing and automated identification for differentiation of selected Enterobacterales, with categorical agreement measured after twenty-four hours: a laboratory-based method-comparison study.
Comparative evaluation of oxidase, pigment, and growth characteristics against automated identification for Pseudomonas aeruginosa, with identification accuracy assessed at final reporting.
Comparative evaluation of conventional biochemical identification and chromogenic medium identification for common urinary pathogens, using automated identification as reference and accuracy assessed at twenty-four hours.
Diagnostic accuracy of chromogenic urine culture media against conventional culture and biochemical identification for common uropathogens, with sensitivity and species concordance assessed at forty-eight hours.
Comparative evaluation of chromogenic and conventional media for detection of mixed urinary cultures, using final isolate identification as reference and additional detection yield assessed at forty-eight hours.
Association of colony colour interpretation on chromogenic urine media with automated species identification, with reader agreement and identification accuracy measured after overnight incubation.
Inter-observer agreement in colony colour interpretation on chromogenic urine media, using automated identification as reference and kappa measured after twenty-four hours.
Diagnostic accuracy of direct positive blood culture identification by conventional rapid biochemical tests against automated identification, with sensitivity and turnaround time assessed during routine workflow.
Comparative evaluation of direct and colony-based automated identification from positive blood cultures, using standard colony identification as reference and agreement assessed on the same day.
Agreement between manual biochemical panels and automated identification for clinically important Enterobacterales, with species concordance and time to final report measured prospectively.
Agreement between manual biochemical testing and automated identification for Staphylococcus species from bloodstream isolates, with species concordance assessed at final reporting.
Agreement between manual and automated identification for Enterococcus species from clinical specimens, with discordant results resolved by repeat conventional testing and agreement assessed prospectively.
Comparative evaluation of automated identification and matrix-assisted laser desorption ionization time-of-flight mass spectrometry for bloodstream isolates where both are routinely available, with species agreement measured same day.
Comparative evaluation of conventional identification and matrix-assisted laser desorption ionization time-of-flight mass spectrometry for non-fermenting Gram-negative bacilli, with species concordance and turnaround time assessed.
Agreement between automated identification and matrix-assisted laser desorption ionization time-of-flight mass spectrometry for clinically significant yeasts where routinely available, with species-level concordance assessed prospectively.
Comparative evaluation of direct colony identification and repeat-subculture identification for mixed bacterial cultures, using final pure-culture identification as reference and turnaround time assessed at forty-eight hours.
Diagnostic accuracy of preliminary urine culture reporting based on colony morphology and simple biochemical tests against final automated identification, with concordance measured within forty-eight hours.
Diagnostic accuracy of preliminary blood culture identification based on Gram stain and rapid biochemical tests against final automated identification, with categorical agreement measured within twenty-four hours.
Association of automated identification confidence scores with concordance to conventional biochemical identification among routine bacterial isolates, with discrepancies assessed at final reporting.
Frequency and causes of discordance between conventional and automated bacterial identification among routine clinical isolates, with discrepancies categorized after repeat testing: a prospective laboratory audit.
Comparative evaluation of turnaround time for conventional and automated bacterial identification among positive blood cultures, with time from positivity to verified species report measured prospectively.
Comparative evaluation of turnaround time for conventional and automated bacterial identification among urine isolates, with time from culture positivity to verified species report measured prospectively.
Frequency of clinically significant identification changes after repeat testing of low-confidence automated results, using conventional biochemical identification as comparator and outcomes assessed at final verification.
Diagnostic yield of repeat identification for unusual or discordant bacterial isolates, using conventional biochemical and automated methods as comparators and final species assignment assessed after verification.
Antimicrobial Susceptibility and Resistance
Antimicrobial Susceptibility Testing
Agreement between disc diffusion and broth microdilution for ciprofloxacin susceptibility among Escherichia coli urinary isolates, using current Clinical and Laboratory Standards Institute breakpoints and categorical agreement assessed after testing.
Agreement between disc diffusion and broth microdilution for gentamicin susceptibility among Enterobacterales clinical isolates, using current Clinical and Laboratory Standards Institute breakpoints and error rates assessed prospectively.
Agreement between disc diffusion and broth microdilution for amikacin susceptibility among Klebsiella pneumoniae isolates, using current Clinical and Laboratory Standards Institute breakpoints and categorical agreement assessed after testing.
Agreement between disc diffusion and broth microdilution for cefepime susceptibility among Enterobacterales isolates, using current Clinical and Laboratory Standards Institute breakpoints and discrepancy rates assessed after testing.
Agreement between disc diffusion and broth microdilution for piperacillin-tazobactam susceptibility among Enterobacterales isolates, using current Clinical and Laboratory Standards Institute breakpoints and categorical agreement assessed prospectively.
Agreement between disc diffusion and broth microdilution for meropenem susceptibility among Enterobacterales isolates, using current Clinical and Laboratory Standards Institute breakpoints and major errors assessed after testing.
Agreement between disc diffusion and broth microdilution for meropenem susceptibility among Pseudomonas aeruginosa isolates, using current Clinical and Laboratory Standards Institute breakpoints and categorical agreement assessed prospectively.
Agreement between disc diffusion and broth microdilution for meropenem susceptibility among Acinetobacter baumannii isolates, using current Clinical and Laboratory Standards Institute breakpoints and discrepancy rates assessed after testing.
Comparative evaluation of disc diffusion and automated susceptibility testing for common antibiotics among Escherichia coli isolates, with categorical agreement measured at final susceptibility reporting.
Comparative evaluation of disc diffusion and automated susceptibility testing among Klebsiella pneumoniae isolates, with essential and categorical agreement assessed using current Clinical and Laboratory Standards Institute breakpoints.
Comparative evaluation of disc diffusion and automated susceptibility testing among Pseudomonas aeruginosa isolates, with categorical agreement and discrepancy rates measured at final reporting.
Comparative evaluation of disc diffusion and automated susceptibility testing among Staphylococcus aureus isolates, with categorical agreement and turnaround time assessed during routine workflow.
Comparative evaluation of disc diffusion and automated susceptibility testing among Enterococcus species, with categorical agreement and discrepancy rates measured using current breakpoints.
Agreement between gradient diffusion and broth microdilution for vancomycin susceptibility among Staphylococcus aureus isolates, using current Clinical and Laboratory Standards Institute breakpoints and essential agreement assessed prospectively.
Agreement between gradient diffusion and broth microdilution for vancomycin susceptibility among Enterococcus species, using current Clinical and Laboratory Standards Institute breakpoints and discrepancy rates assessed prospectively.
Agreement between gradient diffusion and broth microdilution for meropenem susceptibility among carbapenem-nonsusceptible Enterobacterales, with essential and categorical agreement measured after isolate testing.
Comparative evaluation of gradient diffusion and automated susceptibility testing for selected antibiotics among Pseudomonas aeruginosa isolates, with essential agreement assessed at final reporting.
Comparative evaluation of gradient diffusion and automated susceptibility testing for selected antibiotics among Acinetobacter baumannii isolates, with essential agreement assessed at final reporting.
Agreement between manual broth microdilution and automated susceptibility testing for selected antibiotics among Enterobacterales, with categorical and essential agreement assessed prospectively.
Agreement between manual broth microdilution and automated susceptibility testing for selected antibiotics among non-fermenting Gram-negative bacilli, with discrepancy rates assessed using current breakpoints.
Comparative evaluation of direct susceptibility testing from positive blood cultures and standard colony-based disc diffusion, with categorical agreement and reporting-time reduction measured prospectively.
Comparative evaluation of rapid direct disc diffusion from positive blood cultures and conventional susceptibility testing among Enterobacterales, with categorical agreement assessed at final reporting.
Comparative evaluation of rapid direct disc diffusion from positive blood cultures and conventional susceptibility testing among Staphylococcus aureus, with categorical agreement assessed after final susceptibility results.
Association of inoculum density variation with disc diffusion zone diameters among common Enterobacterales, using standardized inoculum as comparator and categorical changes assessed after overnight incubation.
Association of agar depth variation with disc diffusion zone diameters among common bacterial quality-control strains, using recommended depth as comparator and interpretive-category changes assessed after incubation.
Association of delayed disc application with inhibition-zone diameters among common Enterobacterales, using immediate application as comparator and categorical changes assessed after overnight incubation.
Association of incubation duration with disc diffusion interpretation among common Enterobacterales, using recommended incubation as comparator and category changes assessed at predefined reading times.
Association of incubation temperature variation with disc diffusion results among quality-control strains, using recommended temperature as comparator and zone-diameter changes assessed after overnight incubation.
Inter-observer agreement in disc diffusion zone measurement among laboratory personnel, using standardized digital measurement as comparator and kappa assessed across routine clinical isolates.
Agreement between manual ruler and automated zone-reading methods for disc diffusion among Enterobacterales, with measurement differences and categorical agreement assessed after overnight incubation.
Frequency of trailing endpoints during gradient diffusion susceptibility testing among Enterococcus species, using broth microdilution as reference and interpretive discrepancies assessed after incubation.
Frequency of heteroresistant-appearing colonies within inhibition zones among carbapenem-resistant Gram-negative isolates, using repeat susceptibility testing as comparator and reproducibility assessed within forty-eight hours.
Reproducibility of disc diffusion susceptibility testing on repeat testing of Enterobacterales isolates, with zone-diameter variability and categorical agreement assessed on consecutive days.
Reproducibility of gradient diffusion minimum inhibitory concentration measurements among Staphylococcus aureus isolates, with within-isolate variability assessed on consecutive testing days.
Reproducibility of broth microdilution minimum inhibitory concentration measurements among Enterococcus species, with essential agreement assessed on duplicate testing of stored isolates.
Comparative evaluation of manual and automated minimum inhibitory concentration determination for vancomycin among Staphylococcus aureus, with essential agreement assessed using current interpretive breakpoints.
Comparative evaluation of manual and automated minimum inhibitory concentration determination for colistin among selected Gram-negative isolates where clinically indicated, with categorical agreement assessed prospectively.
Agreement between broth microdilution and gradient diffusion for linezolid susceptibility among Enterococcus species, using current Clinical and Laboratory Standards Institute breakpoints and essential agreement assessed prospectively.
Agreement between broth microdilution and gradient diffusion for linezolid susceptibility among Staphylococcus aureus isolates, with essential and categorical agreement assessed after testing.
Comparative evaluation of cefoxitin disc diffusion and automated susceptibility testing for methicillin resistance in Staphylococcus aureus, using current Clinical and Laboratory Standards Institute criteria.
Diagnostic accuracy of cefoxitin disc diffusion against routinely available molecular detection of methicillin resistance among Staphylococcus aureus isolates, with sensitivity and specificity assessed after isolate characterization.
Agreement between oxacillin and cefoxitin disc-based methods for methicillin resistance detection in Staphylococcus aureus, using cefoxitin interpretation as reference and discordance assessed after overnight incubation.
Comparative evaluation of vancomycin screening agar and broth microdilution for reduced vancomycin susceptibility among Enterococcus species, with sensitivity and specificity assessed after isolate testing.
Comparative evaluation of disc diffusion and broth microdilution for high-level gentamicin resistance among Enterococcus species, with categorical agreement assessed using current Clinical and Laboratory Standards Institute criteria.
Diagnostic accuracy of disc approximation testing for inducible clindamycin resistance among Staphylococcus aureus, using repeat standardized testing as reference and reproducibility assessed after overnight incubation.
Comparative evaluation of routine automated susceptibility reporting and manual confirmatory testing for unusual resistance phenotypes among Enterobacterales, with discordance frequency assessed at final verification.
Frequency of categorical changes after repeat testing of discordant susceptibility results among Enterobacterales, using broth microdilution as comparator and changes assessed before final reporting.
Frequency of categorical changes after repeat testing of discordant susceptibility results among Staphylococcus aureus, using reference susceptibility methods and final interpretation assessed before reporting.
Comparative evaluation of susceptibility patterns obtained from urine isolates processed by conventional and automated systems, with categorical concordance and turnaround time assessed at final reporting.
Comparative evaluation of susceptibility patterns obtained from bloodstream isolates processed by conventional and automated systems, with categorical concordance and turnaround time assessed prospectively.
Agreement of susceptibility results between duplicate colonies selected from apparently pure urine cultures, with categorical concordance assessed after routine disc diffusion testing: a laboratory-based reliability study.
Agreement of susceptibility results between duplicate colonies from bloodstream isolates, with categorical concordance assessed by routine disc diffusion on the same culture episode.
Association of mixed colony morphology with susceptibility-report changes after isolate purification in urine cultures, with final pure-culture susceptibility used as comparator and changes assessed at forty-eight hours.
Impact of repeat susceptibility testing on final reporting of multidrug-resistant Gram-negative isolates, using initial results as comparator and clinically significant changes assessed before verification.
Comparative turnaround time of disc diffusion and automated susceptibility testing among common bloodstream pathogens, with time from isolate availability to verified report measured prospectively.
Comparative turnaround time of gradient diffusion and broth microdilution for selected resistant isolates, with time to categorical interpretation measured during routine laboratory processing.
Association of delayed susceptibility plate reading with zone-diameter interpretation among Enterobacterales, using standard reading time as comparator and category changes assessed at delayed intervals.
Frequency of skipped wells in broth microdilution among Gram-negative isolates, using repeat testing as comparator and reproducibility of minimum inhibitory concentration endpoints assessed prospectively.
Association of colony age with disc diffusion susceptibility results among Enterobacterales, using fresh overnight growth as comparator and zone-diameter differences measured after incubation.
Association of colony age with vancomycin minimum inhibitory concentration among Staphylococcus aureus, using fresh overnight growth as comparator and essential agreement assessed by broth microdilution.
Antimicrobial Resistance Mechanisms
Association of extended spectrum beta lactamase production with multidrug resistance among Escherichia coli urinary isolates, using phenotypic confirmatory testing and routine susceptibility results assessed at final reporting.
Association of extended spectrum beta lactamase production with multidrug resistance among Klebsiella pneumoniae isolates, using phenotypic confirmatory testing and resistance categories assessed at final reporting.
Association of AmpC beta lactamase production with cephalosporin resistance among Enterobacterales, using phenotypic confirmatory testing and routine susceptibility profiles assessed concurrently.
Association of carbapenemase production with carbapenem resistance levels among Klebsiella pneumoniae, using phenotypic carbapenemase testing and meropenem minimum inhibitory concentration assessed after testing.
Association of carbapenemase production with multidrug resistance among Escherichia coli isolates, using phenotypic confirmatory methods and routine susceptibility profiles assessed at final reporting.
Correlation of enzymatic beta-lactam resistance phenotypes with automated susceptibility patterns among Enterobacterales, with concordance assessed after confirmatory phenotypic testing.
Association of inducible clindamycin resistance with macrolide resistance among Staphylococcus aureus, using disc approximation testing and routine susceptibility categories assessed after overnight incubation.
Association of high-level aminoglycoside resistance with multidrug resistance among Enterococcus species, using disc diffusion and routine susceptibility profiles assessed at final reporting.
Association of reduced vancomycin susceptibility with methicillin resistance among Staphylococcus aureus, using broth microdilution and cefoxitin disc diffusion with outcomes assessed concurrently.
Association of altered penicillin-binding protein phenotype with cefoxitin resistance among Staphylococcus aureus, using routinely available latex agglutination where available and disc diffusion as comparator.
Association of fluoroquinolone resistance with multidrug resistance among Escherichia coli urinary isolates, using routine susceptibility testing and resistance burden assessed at final reporting: a cross-sectional study.
Association of aminoglycoside resistance with multidrug resistance among Klebsiella pneumoniae clinical isolates, using routine susceptibility testing and resistance profiles assessed at final reporting.
Association of carbapenem resistance with reduced susceptibility to other antimicrobial classes among Pseudomonas aeruginosa, using routine susceptibility testing and multidrug resistance assessed at final reporting.
Association of carbapenem resistance with reduced susceptibility to other antimicrobial classes among Acinetobacter baumannii, using routine susceptibility testing and multidrug resistance assessed at final reporting.
Phenotypic assessment of efflux-pump contribution to fluoroquinolone resistance among Pseudomonas aeruginosa isolates using a routinely available inhibitor method, with susceptibility changes measured after incubation.
Phenotypic assessment of efflux-pump contribution to fluoroquinolone resistance among Escherichia coli isolates using a routinely available inhibitor method, with inhibition-zone changes measured after overnight incubation.
Association of efflux-related phenotypic activity with multidrug resistance among Pseudomonas aeruginosa isolates, using inhibitor-based testing and routine susceptibility profiles assessed concurrently.
Association of reduced outer-membrane permeability phenotype with carbapenem resistance among Klebsiella pneumoniae where routine phenotypic testing is available, with meropenem susceptibility assessed concurrently.
Association of mucoid phenotype with multidrug resistance among Pseudomonas aeruginosa isolates, using colony morphology and routine susceptibility testing with outcomes assessed at final reporting.
Association of mucoid phenotype with multidrug resistance among Klebsiella pneumoniae isolates, using colony morphology and routine susceptibility testing with outcomes assessed at final reporting.
Correlation of biofilm strength with ciprofloxacin resistance among Escherichia coli urinary isolates, using microtitre plate biofilm assay and disc diffusion susceptibility assessed concurrently.
Correlation of biofilm strength with carbapenem resistance among Klebsiella pneumoniae isolates, using microtitre plate assay and meropenem susceptibility assessed at final reporting.
Correlation of biofilm strength with carbapenem resistance among Pseudomonas aeruginosa isolates, using microtitre plate assay and routine susceptibility testing assessed concurrently.
Correlation of biofilm strength with multidrug resistance among Acinetobacter baumannii isolates, using microtitre plate assay and routine susceptibility profiles assessed at final reporting.
Association of strong biofilm formation with methicillin resistance among Staphylococcus aureus, using microtitre plate assay and cefoxitin disc diffusion with outcomes assessed after isolate characterization.
Association of strong biofilm formation with vancomycin minimum inhibitory concentration among Staphylococcus aureus, using microtitre plate assay and broth microdilution assessed after isolate characterization.
Association of biofilm formation with high-level aminoglycoside resistance among Enterococcus species, using microtitre plate assay and routine susceptibility testing assessed concurrently.
Comparative antimicrobial susceptibility of strong and weak biofilm-producing Escherichia coli urinary isolates, using microtitre plate classification and routine disc diffusion outcomes at final reporting.
Comparative antimicrobial susceptibility of strong and weak biofilm-producing Klebsiella pneumoniae isolates, using microtitre plate classification and routine susceptibility outcomes at final reporting.
Comparative antimicrobial susceptibility of strong and weak biofilm-producing Pseudomonas aeruginosa isolates, using microtitre plate classification and routine susceptibility outcomes at final reporting.
Association of prior carbapenem exposure with carbapenem-resistant Enterobacterales infection, using carbapenem-susceptible Enterobacterales as comparator and exposure assessed during the preceding ninety days.
Association of prior fluoroquinolone exposure with fluoroquinolone-resistant Escherichia coli urinary infection, using susceptible infections as comparator and antibiotic exposure assessed during the preceding ninety days.
Association of prior broad-spectrum cephalosporin exposure with extended spectrum beta lactamase-producing Enterobacterales infection, using non-producing isolates as comparator and exposure assessed over ninety days.
Association of prolonged hospitalisation with acquisition of multidrug-resistant Gram-negative infection, using susceptible infections as comparator and duration before culture positivity measured during admission.
Association of intensive-care stay with carbapenem-resistant Gram-negative infection, using ward-acquired susceptible Gram-negative infections as comparator and exposure assessed before culture positivity.
Beta-Lactam Resistance
Prevalence of extended spectrum beta lactamase production among Escherichia coli urinary isolates using combination-disc testing, with resistance patterns assessed at final susceptibility reporting: a laboratory-based cross-sectional study.
Prevalence of extended spectrum beta lactamase production among Klebsiella pneumoniae clinical isolates using combination-disc testing, with resistance profiles assessed at final reporting: a laboratory-based cross-sectional study.
Comparative prevalence of extended spectrum beta lactamase production among community- and hospital-acquired Enterobacterales, using phenotypic confirmatory testing and clinical classification at specimen collection.
Association of extended spectrum beta lactamase production with recurrent urinary tract infection among Escherichia coli isolates, using non-producing isolates as comparator and recurrence documented within six months.
Association of extended spectrum beta lactamase production with treatment modification among hospitalised patients with Enterobacterales infection, using non-producing isolates as comparator and changes recorded during admission.
Diagnostic accuracy of combination-disc testing against automated susceptibility patterns for extended spectrum beta lactamase detection among Escherichia coli, with sensitivity and specificity assessed after final characterization.
Diagnostic accuracy of double-disc synergy testing against combination-disc testing for extended spectrum beta lactamase detection among Enterobacterales, with agreement assessed after overnight incubation.
Agreement between ceftazidime- and cefotaxime-based confirmatory methods for extended spectrum beta lactamase detection among Enterobacterales, with discordance assessed after repeat phenotypic testing.
Association of extended spectrum beta lactamase phenotype with ciprofloxacin resistance among Escherichia coli isolates, using routine susceptibility testing and resistance proportions assessed at final reporting.
Association of extended spectrum beta lactamase phenotype with aminoglycoside resistance among Klebsiella pneumoniae isolates, using routine susceptibility testing and resistance proportions assessed at final reporting.
Prevalence of AmpC beta lactamase production among cefoxitin-resistant Enterobacterales using phenotypic confirmatory testing, with species distribution and resistance patterns assessed at final reporting.
Diagnostic accuracy of cefoxitin screening for AmpC beta lactamase production among Enterobacterales, using phenotypic confirmatory testing as reference and sensitivity assessed after overnight incubation.
Agreement between two phenotypic AmpC beta lactamase detection methods among Enterobacterales, with concordance and discordant-isolate characteristics assessed after repeat testing.
Association of AmpC beta lactamase production with multidrug resistance among Escherichia coli isolates, using phenotypic confirmatory testing and routine susceptibility profiles assessed concurrently.
Association of AmpC beta lactamase production with multidrug resistance among Klebsiella pneumoniae isolates, using phenotypic confirmatory testing and routine susceptibility profiles assessed concurrently.
Frequency of co-production of extended spectrum and AmpC beta lactamases among cephalosporin-resistant Enterobacterales, using phenotypic confirmatory methods and resistance profiles assessed at final reporting.
Association of combined extended spectrum and AmpC beta lactamase phenotypes with carbapenem nonsusceptibility among Enterobacterales, using routine susceptibility testing and outcomes assessed at final reporting.
Prevalence of carbapenemase production among carbapenem-resistant Enterobacterales using modified carbapenem inactivation testing, with species distribution and resistance patterns assessed at final reporting.
Diagnostic accuracy of modified carbapenem inactivation testing for carbapenemase detection among carbapenem-resistant Enterobacterales, using routinely available molecular testing as reference where available.
Agreement between modified carbapenem inactivation testing and carbapenem minimum inhibitory concentration among Enterobacterales, with phenotypic concordance assessed after isolate characterization.
Prevalence of carbapenemase production among Klebsiella pneumoniae isolates from intensive-care patients, using phenotypic confirmatory testing and resistance profiles assessed at final reporting.
Prevalence of carbapenemase production among Escherichia coli clinical isolates, using phenotypic confirmatory testing and specimen-source distribution assessed at final reporting.
Association of carbapenemase production with bloodstream infection mortality among Klebsiella pneumoniae isolates, using non-carbapenemase-producing isolates as comparator and outcome assessed at discharge.
Association of carbapenemase production with prolonged hospitalisation among patients with Enterobacterales infection, using non-producing isolates as comparator and length of stay measured until discharge.
Association of carbapenemase production with prior carbapenem exposure among Enterobacterales infections, using non-producing isolates as comparator and exposure assessed during the preceding ninety days.
Diagnostic accuracy of meropenem disc screening for carbapenemase production among Enterobacterales, using phenotypic confirmatory testing as reference and sensitivity assessed after overnight incubation.
Diagnostic accuracy of ertapenem disc screening for carbapenemase production among Enterobacterales, using phenotypic confirmatory testing as reference and sensitivity assessed after overnight incubation.
Agreement between meropenem and ertapenem screening for carbapenemase-producing Enterobacterales, using phenotypic confirmatory testing as reference and categorical agreement assessed after incubation.
Prevalence of metallo-beta-lactamase phenotype among carbapenem-resistant Pseudomonas aeruginosa using routinely available inhibitor-based testing, with resistance profiles assessed at final reporting.
Prevalence of metallo-beta-lactamase phenotype among carbapenem-resistant Acinetobacter baumannii using routinely available inhibitor-based testing, with resistance profiles assessed at final reporting.
Prevalence of metallo-beta-lactamase phenotype among carbapenem-resistant Enterobacterales using inhibitor-based testing, with species distribution and routine susceptibility profiles assessed at final reporting.
Diagnostic accuracy of inhibitor-based metallo-beta-lactamase testing against routinely available molecular detection among carbapenem-resistant Enterobacterales, with sensitivity and specificity assessed after characterization.
Agreement between two phenotypic metallo-beta-lactamase detection methods among carbapenem-resistant Gram-negative bacilli, with concordance assessed after repeat testing.
Association of metallo-beta-lactamase phenotype with multidrug resistance among Pseudomonas aeruginosa, using inhibitor-based testing and routine susceptibility profiles assessed at final reporting.
Association of metallo-beta-lactamase phenotype with multidrug resistance among Acinetobacter baumannii, using inhibitor-based testing and routine susceptibility profiles assessed at final reporting.
Association of metallo-beta-lactamase phenotype with bloodstream infection mortality among carbapenem-resistant Gram-negative isolates, using non-producing isolates as comparator and outcome assessed at discharge.
Frequency of discordance between carbapenem minimum inhibitory concentration and phenotypic carbapenemase detection among Enterobacterales, with discordant isolates re-tested and classified at final verification.
Frequency of carbapenemase-negative carbapenem resistance among Enterobacterales, using phenotypic carbapenemase testing and routine susceptibility results with prevalence assessed at final reporting.
Comparative resistance profiles of carbapenemase-producing and non-producing carbapenem-resistant Klebsiella pneumoniae, using phenotypic testing and routine susceptibility results assessed concurrently.
Comparative resistance profiles of carbapenemase-producing and non-producing carbapenem-resistant Escherichia coli, using phenotypic testing and routine susceptibility results assessed concurrently.
Association of extended spectrum beta lactamase production with carbapenem susceptibility among Enterobacterales, using phenotypic confirmatory testing and minimum inhibitory concentration categories assessed concurrently.
Association of AmpC beta lactamase production with carbapenem susceptibility among Enterobacterales, using phenotypic confirmatory testing and minimum inhibitory concentration categories assessed concurrently.
Association of combined beta-lactamase phenotypes with multidrug resistance among Enterobacterales, using routine phenotypic tests and susceptibility results assessed at final reporting.
Distribution of beta-lactam resistance phenotypes among neonatal sepsis Enterobacterales isolates, using routine confirmatory tests and antimicrobial susceptibility patterns assessed during the same admission.
Distribution of beta-lactam resistance phenotypes among adult bloodstream Enterobacterales isolates, using routine confirmatory tests and antimicrobial susceptibility patterns assessed at final reporting.
Gram-Positive Resistance
Prevalence of methicillin resistance among Staphylococcus aureus isolates from pus and wound specimens using cefoxitin disc diffusion, with antimicrobial resistance profiles assessed at final reporting.
Prevalence of methicillin resistance among Staphylococcus aureus bloodstream isolates using cefoxitin disc diffusion, with specimen-source characteristics and susceptibility profiles assessed at final reporting.
Association of methicillin resistance with multidrug resistance among Staphylococcus aureus clinical isolates, using cefoxitin disc diffusion and routine susceptibility profiles assessed concurrently.
Association of methicillin resistance with biofilm formation among Staphylococcus aureus, using cefoxitin disc diffusion and microtitre plate assay with outcomes assessed after isolate characterization.
Association of methicillin resistance with clinical outcome among Staphylococcus aureus bloodstream infections, using cefoxitin disc diffusion and mortality assessed at discharge: a retrospective observational study.
Diagnostic accuracy of cefoxitin disc diffusion for methicillin resistance among Staphylococcus aureus, using routinely available molecular detection as reference and sensitivity assessed after isolate characterization.
Agreement between cefoxitin disc diffusion and automated methicillin susceptibility reporting among Staphylococcus aureus, with categorical concordance assessed using current Clinical and Laboratory Standards Institute criteria.
Prevalence of methicillin resistance among coagulase-negative staphylococci from clinically significant blood cultures, using cefoxitin-based testing and resistance profiles assessed at final reporting.
Association of methicillin resistance with device-associated bloodstream infection among coagulase-negative staphylococci, using non-device isolates as comparator and exposure assessed during admission.
Distribution of vancomycin minimum inhibitory concentrations among methicillin-resistant Staphylococcus aureus isolates, using broth microdilution and susceptibility categories assessed after isolate characterization.
Agreement between gradient diffusion and broth microdilution for vancomycin minimum inhibitory concentration among Staphylococcus aureus, with essential agreement assessed prospectively.
Prevalence of reduced vancomycin susceptibility among Staphylococcus aureus isolates using broth microdilution, with methicillin resistance and clinical source assessed at final reporting.
Association of higher vancomycin minimum inhibitory concentration within the susceptible range with methicillin resistance among Staphylococcus aureus, using broth microdilution and cefoxitin testing concurrently.
Association of vancomycin minimum inhibitory concentration with persistent bacteraemia among Staphylococcus aureus bloodstream isolates, with repeat culture positivity assessed within seven days.
Prevalence of vancomycin resistance among Enterococcus faecalis and Enterococcus faecium isolates using broth microdilution, with species distribution and resistance profiles assessed at final reporting.
Association of vancomycin resistance with multidrug resistance among Enterococcus species, using broth microdilution and routine susceptibility profiles assessed concurrently.
Association of vancomycin resistance with intensive-care exposure among Enterococcus bloodstream isolates, using vancomycin-susceptible isolates as comparator and exposure assessed before culture positivity.
Association of vancomycin resistance with prior glycopeptide exposure among Enterococcus infections, using susceptible isolates as comparator and antibiotic exposure assessed during the preceding ninety days.
Comparative resistance profiles of Enterococcus faecalis and Enterococcus faecium clinical isolates, using routine disc diffusion and broth microdilution with species differences assessed at final reporting.
Prevalence of high-level aminoglycoside resistance among Enterococcus species using disc diffusion, with vancomycin susceptibility and multidrug resistance assessed at final reporting.
Association of high-level gentamicin resistance with vancomycin resistance among Enterococcus species, using routine susceptibility methods and resistance categories assessed concurrently.
Prevalence of inducible clindamycin resistance among Staphylococcus aureus isolates using disc approximation testing, with methicillin resistance status assessed at final susceptibility reporting.
Association of inducible clindamycin resistance with methicillin resistance among Staphylococcus aureus, using disc approximation and cefoxitin testing with outcomes assessed after overnight incubation.
Comparative frequency of inducible clindamycin resistance among community- and hospital-acquired Staphylococcus aureus isolates, using disc approximation testing and clinical classification at specimen collection.
Association of inducible clindamycin resistance with specimen source among Staphylococcus aureus isolates, using disc approximation testing and source categories assessed at final reporting.
Prevalence of constitutive and inducible clindamycin resistance phenotypes among coagulase-negative staphylococci, using disc approximation testing and routine susceptibility results assessed concurrently.
Agreement between automated clindamycin susceptibility reporting and disc approximation testing among erythromycin-resistant Staphylococcus aureus, with discordance assessed after overnight incubation.
Association of linezolid resistance with multidrug resistance among Enterococcus species, using broth microdilution or validated automated testing and resistance profiles assessed at final reporting.
Association of linezolid resistance with vancomycin resistance among Enterococcus species, using broth microdilution and routine susceptibility testing with outcomes assessed concurrently.
Retrospective surveillance of Gram-positive antimicrobial resistance among Staphylococcus aureus and Enterococcus isolates over three years, using annual susceptibility data and temporal changes assessed by calendar year.
Multidrug Resistance
Prevalence and antimicrobial profile of multidrug-resistant Escherichia coli from urinary specimens, using routine susceptibility testing and resistance proportions assessed at final laboratory reporting: a cross-sectional study.
Prevalence and antimicrobial profile of multidrug-resistant Klebsiella pneumoniae from respiratory specimens, using routine susceptibility testing and resistance proportions assessed at final reporting.
Prevalence and antimicrobial profile of multidrug-resistant Pseudomonas aeruginosa from clinical specimens, using routine susceptibility testing and resistance proportions assessed at final reporting.
Prevalence and antimicrobial profile of multidrug-resistant Acinetobacter baumannii from intensive-care specimens, using routine susceptibility testing and resistance proportions assessed at final reporting.
Prevalence of multidrug-resistant Enterobacterales among neonatal sepsis isolates, using routine susceptibility testing and species-specific resistance patterns assessed during the same admission.
Prevalence of multidrug-resistant Gram-negative bacilli among adult bloodstream isolates, using routine susceptibility testing and resistance patterns assessed at final reporting.
Comparative prevalence of multidrug resistance among intensive-care and general-ward Gram-negative isolates, using routine susceptibility testing and ward location at specimen collection.
Comparative prevalence of multidrug resistance among community- and hospital-acquired urinary Enterobacterales, using routine susceptibility testing and acquisition classification at specimen collection.
Association of multidrug resistance with prior hospitalisation among urinary Enterobacterales infections, using non-multidrug-resistant infections as comparator and exposure assessed over ninety days.
Association of multidrug resistance with prior antibiotic exposure among Enterobacterales infections, using susceptible infections as comparator and antimicrobial use assessed during the preceding ninety days.
Association of multidrug resistance with urinary catheterisation among Enterobacterales urinary isolates, using non-catheterized patients as comparator and device exposure assessed at specimen collection.
Association of multidrug resistance with mechanical ventilation among Gram-negative respiratory isolates, using non-ventilated patients as comparator and exposure assessed before culture positivity.
Association of multidrug resistance with central venous catheter exposure among bloodstream Gram-negative isolates, using susceptible bloodstream infections as comparator and exposure assessed during admission.
Association of multidrug resistance with prolonged hospitalisation among Gram-negative infections, using susceptible infections as comparator and pre-culture length of stay measured during admission.
Association of multidrug resistance with in-hospital mortality among Gram-negative bloodstream infections, using susceptible isolates as comparator and outcome assessed at discharge.
Association of multidrug resistance with thirty-day mortality among adult bloodstream infections, using non-multidrug-resistant isolates as comparator and outcome obtained from hospital records.
Association of multidrug resistance with treatment modification among hospitalised patients with Enterobacterales infection, using susceptible isolates as comparator and antimicrobial changes recorded during admission.
Association of multidrug resistance with length of hospital stay among patients with Klebsiella pneumoniae infection, using susceptible isolates as comparator and stay measured until discharge.
Frequency of extensively drug-resistant Acinetobacter baumannii among intensive-care isolates, using routine susceptibility testing and remaining active antimicrobial categories assessed at final reporting.
Frequency of extensively drug-resistant Pseudomonas aeruginosa among intensive-care isolates, using routine susceptibility testing and remaining active antimicrobial categories assessed at final reporting.
Clinical characteristics of extensively drug-resistant Gram-negative infections compared with multidrug-resistant infections, using routine susceptibility definitions and discharge outcomes assessed during the same admission.
Association of extensively drug-resistant phenotype with mortality among Acinetobacter baumannii infections, using multidrug-resistant non-extensively resistant isolates as comparator and outcome assessed at discharge.
Association of extensively drug-resistant phenotype with invasive-device exposure among Gram-negative infections, using multidrug-resistant comparator isolates and exposure assessed before culture positivity.
Frequency of isolates meeting possible pandrug-resistant phenotypic criteria among intensive-care Gram-negative bacilli, using complete routinely available susceptibility panels and confirmatory repeat testing before classification.
Verification of possible pandrug-resistant Gram-negative isolates by repeat broth microdilution, using initial routine susceptibility results as comparator and final resistance category assigned after confirmation.
Retrospective three-year surveillance of multidrug-resistant Gram-negative bacilli in intensive-care units, using laboratory susceptibility records and annual resistance proportions compared across calendar years.
Retrospective three-year surveillance of multidrug-resistant urinary Enterobacterales, using laboratory susceptibility records and annual resistance proportions compared across calendar years.
Retrospective three-year surveillance of multidrug-resistant bloodstream isolates in neonates, using laboratory records and annual species-specific resistance proportions compared across calendar years.
Comparison of cumulative antibiograms from intensive-care and general wards for major Gram-negative pathogens, using annual laboratory data and resistance differences assessed for the same year.
Development and validation of a local risk score for multidrug-resistant Gram-negative infection among hospitalised adults, using routine clinical variables and culture-confirmed resistance outcome during admission.
Molecular Detection of Resistance
Diagnostic accuracy of conventional polymerase chain reaction for selected extended spectrum beta lactamase genes among Escherichia coli isolates, using phenotypic confirmatory testing as comparator and concordance assessed after characterization.
Diagnostic accuracy of conventional polymerase chain reaction for selected extended spectrum beta lactamase genes among Klebsiella pneumoniae isolates, using phenotypic testing as comparator and concordance assessed after characterization.
Agreement between conventional polymerase chain reaction and phenotypic carbapenemase testing among carbapenem-resistant Enterobacterales, with genotype-phenotype concordance assessed after isolate characterization.
Agreement between conventional polymerase chain reaction and inhibitor-based metallo-beta-lactamase testing among carbapenem-resistant Gram-negative isolates, with concordance assessed after completion of both methods.
Association of selected carbapenemase genes with meropenem minimum inhibitory concentration among Klebsiella pneumoniae isolates, using conventional polymerase chain reaction and broth microdilution assessed concurrently.
Association of selected resistance genes with multidrug resistance among Escherichia coli isolates, using conventional polymerase chain reaction and routine susceptibility profiles assessed after characterization.
Association of selected methicillin resistance genes with cefoxitin resistance among Staphylococcus aureus, using conventional polymerase chain reaction and disc diffusion with concordance assessed after testing.
Association of selected vancomycin resistance genes with phenotypic resistance among Enterococcus species, using conventional polymerase chain reaction and broth microdilution with concordance assessed after testing.
Association of selected macrolide-lincosamide resistance genes with inducible clindamycin resistance among Staphylococcus aureus, using conventional polymerase chain reaction and disc approximation testing.
Comparative detection of selected resistance genes by single-target and multiplex polymerase chain reaction among Enterobacterales, with agreement and turnaround time assessed after isolate characterization.
Diagnostic yield of multiplex polymerase chain reaction for common carbapenemase genes among carbapenem-resistant Enterobacterales, using phenotypic carbapenemase testing as comparator.
Genotypic-phenotypic concordance of fluoroquinolone resistance among Escherichia coli isolates using routinely available molecular markers and disc diffusion, with agreement assessed after characterization.
Genotypic-phenotypic concordance of aminoglycoside resistance among Klebsiella pneumoniae isolates using routinely available molecular markers and routine susceptibility testing, with agreement assessed after characterization.
Frequency of phenotypic resistance without detected target genes among carbapenem-resistant Enterobacterales, using routine polymerase chain reaction panels and phenotypic confirmatory testing.
Frequency of resistance-gene carriage among phenotypically susceptible Enterobacterales, using routinely available polymerase chain reaction and repeat susceptibility testing before final classification.
Association of resistance-gene combinations with extensively drug-resistant phenotype among Klebsiella pneumoniae isolates, using routine polymerase chain reaction and susceptibility testing assessed after characterization.
Comparative turnaround time of phenotypic and routine molecular resistance detection among carbapenem-resistant Enterobacterales, with time from isolate availability to verified result measured prospectively.
Concordance of automated susceptibility testing with routine polymerase chain reaction for selected resistance markers among bloodstream Gram-negative isolates, with discordant results characterized after repeat testing.
Retrospective genotype-phenotype correlation of routinely tested carbapenemase-positive Enterobacterales isolates, using molecular laboratory records and susceptibility profiles from the same isolate episode.
Limited sequence confirmation of selected discordant resistance-gene amplicons among stored Enterobacterales where sequencing is routinely available, with sequence results compared with phenotype after characterization.
Sterilization and Disinfection
Physical Methods
Audit of autoclave cycle parameters against biological indicator results in a teaching hospital central sterilization unit, with concordance assessed for routine cycles over six months.
Agreement between mechanical autoclave monitoring and biological indicator results for routine sterilization cycles, with discordance frequency assessed at completion of each cycle: a prospective audit.
Agreement between chemical indicators and biological indicators for routine steam sterilization cycles, with sensitivity for cycle failure assessed over six months: a hospital-based observational study.
Frequency of failed steam sterilization cycles detected by biological indicators in hospital sterilization units, with mechanical and chemical monitoring findings compared at each tested cycle.
Association of autoclave load type with biological indicator failure, using routine sterilization records and outcomes assessed at completion of each monitored cycle: a prospective observational study.
Association of autoclave load density with chemical indicator penetration, using routine indicator results and cycle parameters assessed immediately after sterilization: a hospital-based observational study.
Comparative evaluation of sterilization indicators placed at different load positions in steam autoclaves, with indicator pass rates assessed after each routine cycle.
Association of preventive maintenance status with autoclave monitoring failures, using service records and biological indicator outcomes assessed over a six-month surveillance period.
Comparative evaluation of gravity-displacement and pre-vacuum steam cycles where routinely used, with biological and chemical indicator pass rates assessed after each cycle.
Audit of dry-heat sterilizer temperature-time records against chemical indicator results, with cycle compliance and failures assessed over six months.
Agreement between mechanical monitoring and chemical indicators for dry-heat sterilization cycles, with discordance assessed at cycle completion: a prospective observational study.
Association of instrument load type with dry-heat sterilization monitoring outcomes, using routine chemical indicators and cycle parameters assessed immediately after processing.
Microbiological assessment of reusable laboratory glassware before and after routine dry-heat sterilization, using culture negativity as reference and sterility assessed after incubation.
Comparative sterility of glassware processed by steam and dry-heat methods for items routinely suitable for both, using post-processing culture and sterility assessed after incubation.
Microbiological assessment of membrane filtration effectiveness for routinely prepared heat-labile laboratory solutions, using pre- and post-filtration culture with sterility assessed after incubation.
Comparative bacterial recovery before and after routine membrane filtration of laboratory solutions, using quantitative culture and reduction in viable counts assessed immediately after filtration.
Audit of filter-integrity checks for routine laboratory filtration processes, using documented integrity tests and post-filtration sterility results assessed over six months.
Microbiological surveillance of ultraviolet disinfection in biosafety cabinets, using surface cultures before and after routine exposure and reduction in colony counts measured immediately.
Comparative surface bioburden before and after routine ultraviolet exposure in selected laboratory workspaces, using standardized contact cultures and reduction assessed on the same day.
Audit of ultraviolet lamp maintenance and exposure practices in microbiology laboratories, using documented lamp age and surface culture results assessed over six months.
Chemical Disinfectants
Comparative reduction in surface bacterial counts after routine seventy-percent alcohol cleaning versus standard detergent cleaning of laboratory benches, using pre- and post-cleaning cultures assessed immediately.
Microbiological efficacy of alcohol-based surface disinfection on frequently touched laboratory surfaces, using standardized cultures before and after cleaning with colony-count reduction measured immediately.
Association of contact time with alcohol-based disinfectant efficacy on laboratory surfaces, using standardized pre- and post-disinfection cultures and colony-count reduction assessed immediately.
Comparative efficacy of two routinely used alcohol formulations for reducing bacterial contamination of work surfaces, using standardized cultures and percentage colony reduction measured after disinfection.
Audit of aldehyde-based high-level disinfection practices for reusable equipment against institutional protocol, with process-compliance and microbiological surveillance outcomes assessed over six months.
Microbiological assessment of reusable equipment before and after routine aldehyde-based high-level disinfection, using culture positivity and colony-count reduction assessed after processing.
Association of disinfectant concentration accuracy with microbial culture outcomes in high-level disinfection, using routine concentration records and post-processing cultures assessed over six months.
Comparative efficacy of freshly prepared and end-of-use chlorine solutions for environmental disinfection, using standardized surface cultures and colony reduction measured after routine contact time.
Association of chlorine concentration with reduction of bacterial contamination on hospital surfaces, using pre- and post-cleaning cultures and colony-count reduction assessed immediately.
Audit of chlorine solution preparation in clinical areas against institutional protocol, with concentration accuracy and environmental culture results assessed over six months.
Comparative microbiological efficacy of chlorine-based and hydrogen peroxide-based surface disinfection in selected hospital areas, using pre- and post-disinfection cultures and colony reduction measured immediately.
Microbiological efficacy of hydrogen peroxide-based cleaning on high-touch intensive-care surfaces, using standardized cultures before and after cleaning with colony-count reduction assessed immediately.
Association of hydrogen peroxide contact time with environmental bacterial reduction, using routine hospital surfaces and standardized cultures assessed before and after disinfection.
Comparative efficacy of hydrogen peroxide and routine quaternary ammonium compound cleaning for intensive-care surfaces, using standardized cultures and post-cleaning colony counts.
Microbiological efficacy of quaternary ammonium compounds for routine ward-surface disinfection, using pre- and post-cleaning cultures and percentage reduction in colony counts measured immediately.
Association of disinfectant dilution accuracy with surface decontamination efficacy for quaternary ammonium compounds, using standardized cultures and post-cleaning bacterial counts.
Comparative microbial contamination of disinfectant solutions at preparation and end of use, using routine culture and contamination frequency assessed over working shifts.
Microbiological surveillance of reusable cleaning solutions in hospital wards, using culture and organism identification with contamination prevalence assessed at scheduled sampling points.
Audit of disinfectant preparation, labelling, and expiry practices in hospital areas against institutional policy, with compliance proportions assessed monthly over six months.
Association of staff compliance with disinfectant preparation protocol and environmental culture positivity, using observational audit and standardized surface cultures assessed during the same period.
Sterility Monitoring
Agreement between biological, chemical, and mechanical indicators for routine steam sterilization cycles, with discordant cycles characterized immediately after processing: a prospective observational study.
Diagnostic performance of chemical indicators for detecting steam sterilization failure, using biological indicators as reference and sensitivity assessed across routine cycles over six months.
Association of mechanical parameter deviations with biological indicator positivity during steam sterilization, using routine cycle records and outcomes assessed after incubation of indicators.
Frequency and causes of biological indicator failure in hospital autoclaves, using cycle records and maintenance documentation with causes classified after each failed cycle.
Comparative performance of biological indicators placed at central and peripheral load positions, with positive indicator frequency assessed after routine sterilization cycles.
Reproducibility of biological indicator results in duplicate placements during steam sterilization, with agreement assessed after incubation across routine cycles.
Association of autoclave load category with biological indicator performance, using routine cycle records and indicator results assessed after incubation.
Association of autoclave age and maintenance history with biological indicator failure, using equipment records and monitoring outcomes assessed over six months.
Agreement between internal and external chemical indicators for packaged sterilization loads, with concordance assessed immediately after routine cycle completion.
Frequency of chemical indicator failures despite acceptable mechanical parameters during steam sterilization, with discordance assessed over six months of routine cycles.
Association of packaging material with chemical indicator penetration during steam sterilization, using routinely used packs and indicator outcomes assessed immediately after processing.
Comparative performance of chemical indicators in densely and loosely packed instrument loads, with pass rates assessed immediately following routine sterilization cycles.
Audit of mechanical monitoring documentation for steam sterilizers against hospital policy, with completeness and deviation rates assessed over a six-month period.
Association of mechanical monitoring deviations with repeat sterilization cycles, using sterilization records and repeat-processing frequency assessed monthly over six months.
Comparative accuracy of manually recorded and electronically logged autoclave parameters where both are available, with agreement assessed for routine cycles over six months.
Frequency of undocumented sterilization cycles in hospital sterilization units, using machine logs as comparator and documentation compliance assessed monthly.
Correlation of temperature, pressure, and holding time with chemical indicator outcomes in steam sterilization, using routine mechanical records and indicators assessed at cycle completion.
Development and validation of a simple sterilization-monitoring checklist against complete institutional records, with checklist sensitivity for process deviations assessed over six months.
Audit of corrective actions after failed sterilization indicators, using departmental protocols as reference and completion of required actions assessed within twenty-four hours.
Association of staff training status with completeness of sterilization monitoring documentation, using training records and audit scores assessed during the same six-month period.
Disinfection of Hospital Equipment
Microbiological surveillance of flexible endoscopes before and after routine high-level disinfection, using culture positivity as outcome and results assessed after each sampled reprocessing cycle.
Audit of flexible endoscope reprocessing against institutional protocol, with procedural compliance and post-disinfection culture positivity assessed over six months.
Association of endoscope drying practices with post-reprocessing bacterial contamination, using standardized cultures and contamination assessed before subsequent clinical use.
Comparative contamination of endoscope channels before and after routine high-level disinfection, using quantitative culture and reduction in bacterial counts assessed after processing.
Association of endoscope storage duration with bacterial contamination after high-level disinfection, using scheduled cultures and contamination assessed before clinical reuse.
Microbiological assessment of surgical instruments before and after routine sterilization, using standardized cultures and sterility assessed after incubation: a prospective observational study.
Audit of surgical instrument decontamination and sterilization practices against institutional protocol, with compliance proportions and failed monitoring results assessed over six months.
Association of instrument complexity with residual contamination after cleaning but before sterilization, using standardized cultures and contamination frequency assessed during routine reprocessing.
Comparative microbial contamination of hinged and non-hinged surgical instruments after routine cleaning, using culture positivity and colony counts assessed before sterilization.
Association of pre-cleaning delay with residual microbial contamination on surgical instruments, using routine workflow intervals and cultures obtained after cleaning.
Microbiological surveillance of ventilator touch surfaces before and after routine intensive-care cleaning, using standardized cultures and colony-count reduction measured immediately.
Microbiological surveillance of bedside monitors before and after routine intensive-care disinfection, using standardized surface cultures and colony-count reduction measured immediately.
Microbiological surveillance of infusion pumps before and after routine intensive-care disinfection, using standardized cultures and reduction in bacterial contamination measured immediately.
Comparative contamination of frequently touched intensive-care equipment across shifts, using standardized surface cultures and colony counts assessed at predefined daily time points.
Association of cleaning frequency with bacterial contamination of intensive-care equipment, using cleaning records and standardized surface cultures assessed over six months.
Microbiological surveillance of laboratory centrifuge surfaces before and after routine disinfection, using standardized cultures and colony-count reduction assessed immediately.
Microbiological surveillance of biosafety cabinet work surfaces before and after routine disinfection, using standardized cultures and colony-count reduction assessed immediately.
Microbiological surveillance of automated analyzer touch surfaces before and after routine cleaning, using standardized cultures and bacterial contamination assessed immediately.
Comparative contamination of shared laboratory equipment before and after implementation of a standardized cleaning checklist, using surface cultures and colony counts assessed over three months.
Audit of laboratory equipment disinfection practices against departmental policy, with compliance scores and environmental culture positivity assessed concurrently over six months.
Microbial Genetics and Molecular Microbiology
Conventional PCR
Diagnostic accuracy of conventional polymerase chain reaction for Mycobacterium tuberculosis complex in selected extrapulmonary specimens, using mycobacterial culture as reference and sensitivity assessed at final culture reporting.
Agreement between conventional polymerase chain reaction and cartridge-based nucleic acid amplification testing for Mycobacterium tuberculosis complex in extrapulmonary specimens, with concordance assessed during the same episode.
Diagnostic accuracy of conventional polymerase chain reaction for selected carbapenemase genes in carbapenem-resistant Enterobacterales, using phenotypic carbapenemase testing as comparator and concordance assessed after characterization.
Diagnostic accuracy of conventional polymerase chain reaction for selected extended spectrum beta lactamase genes in Escherichia coli, using phenotypic confirmation as comparator and concordance assessed after characterization.
Association of selected virulence genes with biofilm formation among uropathogenic Escherichia coli, using conventional polymerase chain reaction and microtitre plate assay assessed after isolate characterization.
Association of selected virulence genes with biofilm formation among Klebsiella pneumoniae, using conventional polymerase chain reaction and microtitre plate assay assessed after isolate characterization.
Diagnostic accuracy of conventional polymerase chain reaction for selected methicillin resistance genes among Staphylococcus aureus, using cefoxitin disc diffusion as comparator and concordance assessed after testing.
Agreement between conventional polymerase chain reaction and routine antigen testing for selected viral infections where molecular testing is routinely available, with concordance assessed during acute presentation.
Comparative turnaround time of conventional polymerase chain reaction and culture for selected bacterial pathogens, with time from specimen receipt to verified result measured prospectively.
Frequency of inhibition or invalid amplification in routine conventional polymerase chain reaction assays, using repeat testing as comparator and final valid-result rate assessed monthly.
Association of specimen type with conventional polymerase chain reaction positivity for extrapulmonary tuberculosis, using culture and clinical diagnosis as comparators and yield assessed at final diagnosis.
Agreement of duplicate conventional polymerase chain reaction runs for stored bacterial isolates, with reproducibility assessed by concordant amplification after repeat testing.
Real-Time PCR
Diagnostic accuracy of real-time polymerase chain reaction for Mycobacterium tuberculosis complex in extrapulmonary specimens, using mycobacterial culture as reference and performance assessed at final culture reporting.
Agreement between real-time polymerase chain reaction and cartridge-based nucleic acid amplification testing for pulmonary tuberculosis, with concordance and turnaround time assessed during the same diagnostic episode.
Diagnostic accuracy of real-time polymerase chain reaction for dengue virus in early febrile illness, using routine serology as comparator and positivity assessed within the acute episode.
Comparative detection of hepatitis B virus by real-time polymerase chain reaction and routine serological markers, with concordance assessed during the same clinical evaluation.
Association of real-time polymerase chain reaction cycle threshold values with culture positivity in selected bacterial infections where routine testing exists, with results compared during the same episode.
Association of real-time polymerase chain reaction cycle threshold values with clinical severity in routine viral respiratory testing, with severity assessed during the index admission.
Comparative turnaround time of real-time polymerase chain reaction and conventional molecular testing for routinely tested pathogens, with time from receipt to verified result measured prospectively.
Frequency and causes of invalid real-time polymerase chain reaction results in routine diagnostic testing, using repeat testing as comparator and final resolution assessed within forty-eight hours.
Multiplex PCR
Diagnostic yield of multiplex polymerase chain reaction for common bacterial resistance genes among carbapenem-resistant Enterobacterales, using phenotypic carbapenemase testing as comparator and concordance assessed after characterization.
Agreement between multiplex and single-target polymerase chain reaction for selected carbapenemase genes in Enterobacterales, with gene-detection concordance assessed after isolate characterization.
Diagnostic yield of a routinely available multiplex respiratory pathogen assay compared with conventional microbiology in hospitalised patients, with additional detections assessed during the same episode.
Diagnostic yield of a routinely available multiplex meningitis assay compared with culture and microscopy in cerebrospinal fluid, with additional detections assessed during the same admission.
Comparative turnaround time of multiplex molecular testing and conventional microbiology for selected syndromic specimens, with time to verified pathogen result measured prospectively.
Frequency of multiple-pathogen detections by routinely available multiplex assays, using conventional tests as comparator and clinical significance assessed during the same episode.
RT-PCR
Diagnostic accuracy of reverse transcription polymerase chain reaction for dengue virus during early febrile illness, using routine serology and clinical diagnosis as comparators with yield assessed during admission.
Agreement between reverse transcription polymerase chain reaction and antigen testing for dengue virus in acute serum specimens, with concordance assessed according to day of illness.
Diagnostic yield of reverse transcription polymerase chain reaction for influenza virus compared with rapid antigen testing in hospitalised respiratory illness, with concordance assessed during admission.
Agreement between reverse transcription polymerase chain reaction and routine molecular respiratory assays for selected ribonucleic acid viruses, with concordance assessed during the same diagnostic episode.
Association of reverse transcription polymerase chain reaction cycle threshold with illness day in laboratory-confirmed viral infection, with values compared during the acute episode.
Frequency and causes of invalid reverse transcription polymerase chain reaction results in routine viral diagnostics, using repeat testing as comparator and final resolution assessed within forty-eight hours.
Nested PCR
Diagnostic accuracy of nested polymerase chain reaction for selected difficult-to-detect pathogens where routinely available, using established molecular or culture methods as reference and sensitivity assessed after testing.
Comparative sensitivity of nested and conventional polymerase chain reaction for low-burden extrapulmonary tuberculosis specimens, using mycobacterial culture as reference and yield assessed at final reporting.
Frequency of discordant results between nested and conventional polymerase chain reaction in stored positive specimens, with repeat testing used for resolution after molecular analysis.
Audit of contamination-control practices in nested polymerase chain reaction workflows, using negative-control failure as outcome and contamination events assessed over six months.
Digital PCR
Agreement between digital polymerase chain reaction and routinely used real-time polymerase chain reaction for selected archived positive specimens where digital testing is available, with quantitative concordance assessed after testing.
Comparative detection of low-copy target nucleic acid by digital and real-time polymerase chain reaction in stored specimens, with detection agreement assessed after completion of both methods.
Sequencing
Sequence confirmation of selected carbapenemase gene amplicons among phenotypically discordant Enterobacterales isolates, using conventional polymerase chain reaction as index test and concordance assessed after sequencing.
Sequence confirmation of selected extended spectrum beta lactamase gene amplicons among Escherichia coli isolates, using phenotypic testing as comparator and genotype-phenotype concordance assessed after characterization.
Limited sequencing of selected resistance-gene amplicons from unusual Gram-negative isolates, using phenotypic susceptibility as comparator and concordance assessed after sequence interpretation.
Sequence-based confirmation of selected bacterial identification discrepancies where sequencing is routinely available, using automated identification as comparator and final species assignment assessed after analysis.
Comparison of sequence-confirmed and phenotypically inferred resistance mechanisms among selected stored Enterobacterales, with concordance assessed after completion of laboratory characterization.
Retrospective analysis of routinely generated sequence data for selected bacterial resistance markers, using corresponding susceptibility records and genotype-phenotype concordance assessed for the same isolates.
Whole-Genome Sequencing
Retrospective whole-genome analysis of stored carbapenem-resistant Klebsiella pneumoniae isolates where sequencing is routinely available, with resistance determinants compared with phenotypic susceptibility from the same isolates.
Retrospective whole-genome comparison of selected epidemiologically linked bacterial isolates where sequencing is routinely available, with genomic relatedness compared with ward and date overlap.
Metagenomics
Diagnostic yield of routinely available metagenomic testing in culture-negative central nervous system infection, using conventional microbiology as comparator and additional pathogen detections assessed during admission.
Retrospective analysis of clinically performed metagenomic sequencing in unresolved infections, using conventional laboratory results as comparator and incremental diagnostic yield assessed at final diagnosis.
Molecular Epidemiology
Molecular epidemiology of selected carbapenemase genes among carbapenem-resistant Klebsiella pneumoniae from intensive-care units, using routine polymerase chain reaction and ward distribution assessed over twelve months.
Molecular epidemiology of selected carbapenemase genes among Escherichia coli isolates from urine and bloodstream specimens, using routine polymerase chain reaction and source distribution assessed over twelve months.
Distribution of selected methicillin resistance genes among Staphylococcus aureus from community- and hospital-acquired infections, using routine polymerase chain reaction and acquisition category assessed at presentation.
Distribution of selected vancomycin resistance genes among Enterococcus species from different hospital units, using routine polymerase chain reaction and ward distribution assessed over twelve months.
Association of resistance-gene patterns with intensive-care location among carbapenem-resistant Enterobacterales, using routine molecular testing and ward exposure assessed at culture positivity.
Association of resistance-gene patterns with specimen source among carbapenem-resistant Klebsiella pneumoniae, using routine polymerase chain reaction and source categories assessed at final reporting.
Temporal distribution of selected carbapenemase genes among Enterobacterales over twelve months, using routine molecular data and monthly gene frequencies compared prospectively.
Temporal distribution of selected extended spectrum beta lactamase genes among urinary Escherichia coli over twelve months, using routine molecular data and monthly frequencies compared prospectively.
Genotype-phenotype correlation of selected resistance markers among bloodstream Enterobacterales, using routine polymerase chain reaction and susceptibility testing with concordance assessed after characterization.
Molecular characterization of selected virulence genes among recurrent urinary Escherichia coli isolates, using routine polymerase chain reaction and six-month recurrence status from records.
Association of selected virulence-gene patterns with biofilm formation among Klebsiella pneumoniae, using routine polymerase chain reaction and microtitre plate assay assessed after isolate characterization.
Epidemiological clustering of phenotypically similar carbapenem-resistant Enterobacterales using routine resistance-gene profiles, with ward-time overlap assessed during a twelve-month surveillance period.
Microbial Virulence and Host–Pathogen Interaction
Virulence Factors
Association of hypermucoviscous phenotype with invasive infection among Klebsiella pneumoniae clinical isolates, using string testing and non-invasive infections as comparator with outcome classified during admission.
Association of haemolysin production with symptomatic urinary tract infection among Escherichia coli isolates, using routine phenotypic testing and asymptomatic bacteriuria isolates as comparator.
Association of pigment production with invasive disease among Pseudomonas aeruginosa isolates, using routine colony characteristics and bloodstream versus non-bloodstream source as comparator.
Association of coagulase activity with invasive infection among Staphylococcus aureus isolates, using tube coagulase testing and bloodstream versus wound origin as comparator.
Association of selected virulence phenotypes with multidrug resistance among Klebsiella pneumoniae, using routine phenotypic assays and susceptibility testing assessed after isolate characterization.
Association of selected virulence phenotypes with multidrug resistance among Escherichia coli urinary isolates, using routine phenotypic assays and susceptibility testing assessed concurrently.
Association of virulence-associated phenotypes with clinical severity among Pseudomonas aeruginosa infections, using routine laboratory tests and intensive-care admission as outcome during the same episode.
Association of virulence-associated phenotypes with recurrent urinary tract infection among Escherichia coli, using routine laboratory tests and recurrence documented over six months.
Comparative virulence-associated phenotypes of community- and hospital-acquired Staphylococcus aureus isolates, using routine phenotypic tests and acquisition classification at specimen collection.
Correlation of virulence-associated phenotypes with biofilm strength among common Gram-negative pathogens, using routine assays and microtitre plate biofilm quantification after incubation.
Toxins
Association of haemolysin production with antimicrobial resistance among Escherichia coli urinary isolates, using phenotypic haemolysis testing and routine susceptibility results assessed at final reporting.
Association of haemolysin production with recurrent urinary tract infection among Escherichia coli isolates, using routine phenotypic testing and recurrence documented within six months.
Association of toxin-associated phenotype with diarrhoeal severity among culture-confirmed bacterial enteric pathogens, using routine phenotypic or molecular testing and clinical severity assessed during admission.
Diagnostic yield of routine toxin detection compared with culture in antibiotic-associated diarrhoea specimens, with concordance and additional detections assessed during the same diarrhoeal episode.
Association of toxin detection with leukocytosis among patients with culture-supported antibiotic-associated diarrhoea, using routine toxin assay and blood counts obtained within twenty-four hours.
Association of toxin detection with prolonged hospitalisation in antibiotic-associated diarrhoea, using toxin-negative cases as comparator and length of stay assessed until discharge.
Comparative toxin detection by two routinely available immunoassays in diarrhoeal stool specimens, using composite laboratory diagnosis as reference and agreement assessed on the same sample.
Association of toxin-gene detection with phenotypic toxin production among selected bacterial isolates where routine molecular testing exists, with concordance assessed after characterization.
Association of toxin-positive bacterial isolates with intensive-care admission among severe diarrhoeal infections, using toxin-negative isolates as comparator and admission status assessed during the episode.
Retrospective surveillance of laboratory-confirmed toxin-mediated bacterial diarrhoea, using routine toxin assay records and monthly positivity patterns assessed over two years.
Adhesins
Association of biofilm formation as a surrogate adhesion phenotype with recurrent urinary tract infection among Escherichia coli, using microtitre plate assay and recurrence documented within six months.
Association of biofilm formation with catheter-associated urinary infection among Klebsiella pneumoniae, using microtitre plate assay and non-catheter urinary isolates as comparator.
Association of selected adhesin genes with biofilm strength among Escherichia coli urinary isolates, using routine polymerase chain reaction and microtitre plate assay assessed after characterization.
Association of selected adhesin genes with catheter-associated infection among Escherichia coli isolates, using routine polymerase chain reaction and non-catheter infections as comparator.
Comparative adhesion-associated biofilm formation of bloodstream and urinary Klebsiella pneumoniae isolates, using microtitre plate assay and biofilm categories assessed after twenty-four hours.
Comparative adhesion-associated biofilm formation of device- and non-device-associated coagulase-negative staphylococci, using microtitre plate assay and biofilm strength assessed after incubation.
Association of strong adhesion-associated biofilm formation with multidrug resistance among Staphylococcus aureus, using microtitre plate assay and routine susceptibility testing assessed concurrently.
Association of strong adhesion-associated biofilm formation with persistence of Pseudomonas aeruginosa infection, using repeat culture positivity within seven days as outcome.
Comparative adhesion-associated biofilm formation among Escherichia coli isolates from first and recurrent urinary infections, using microtitre plate assay and recurrence status from six-month records.
Correlation of adhesion-associated biofilm phenotype with clinical source among common Enterobacterales, using microtitre plate assay and specimen-source categories assessed at final reporting.
Biofilms
Prevalence of biofilm formation among Escherichia coli urinary isolates using microtitre plate assay, with antimicrobial resistance profiles assessed at final susceptibility reporting: a cross-sectional study.
Prevalence of biofilm formation among Klebsiella pneumoniae clinical isolates using microtitre plate assay, with antimicrobial resistance profiles assessed at final reporting.
Prevalence of biofilm formation among Pseudomonas aeruginosa clinical isolates using microtitre plate assay, with multidrug resistance assessed at final reporting.
Prevalence of biofilm formation among Acinetobacter baumannii intensive-care isolates using microtitre plate assay, with carbapenem resistance assessed concurrently.
Prevalence of biofilm formation among Staphylococcus aureus wound isolates using microtitre plate assay, with methicillin resistance assessed at final reporting.
Prevalence of biofilm formation among Enterococcus species urinary isolates using microtitre plate assay, with high-level aminoglycoside resistance assessed concurrently.
Association of strong biofilm formation with device-associated infection among Gram-negative isolates, using non-device infections as comparator and device status determined at specimen collection.
Association of strong biofilm formation with multidrug resistance among common urinary pathogens, using microtitre plate assay and routine susceptibility profiles assessed concurrently.
Association of strong biofilm formation with prolonged hospitalisation among bloodstream infections, using weak or non-biofilm-producing isolates as comparator and stay measured until discharge.
Association of biofilm strength with recurrent infection among urinary pathogens, using microtitre plate assay and recurrence documented over six months.
Quorum Sensing
Association of pigment production as a quorum-sensing-related phenotype with biofilm strength among Pseudomonas aeruginosa, using colony assessment and microtitre plate assay after incubation.
Association of pigment production with multidrug resistance among Pseudomonas aeruginosa clinical isolates, using routine colony characteristics and susceptibility testing assessed at final reporting.
Association of quorum-sensing-related phenotypic traits with respiratory versus wound origin among Pseudomonas aeruginosa, using routine laboratory assays and source classification at reporting.
Correlation of quorum-sensing-associated pigment intensity with biofilm formation among Pseudomonas aeruginosa, using standardized visual grading and microtitre plate assay assessed after incubation.
Association of quorum-sensing-related phenotypes with carbapenem resistance among Pseudomonas aeruginosa, using routine phenotypic assays and meropenem susceptibility assessed concurrently.
Comparative quorum-sensing-related phenotypes of intensive-care and general-ward Pseudomonas aeruginosa isolates, using routine assays and ward location at specimen collection.
Association of quorum-sensing-related phenotypes with persistent Pseudomonas aeruginosa infection, using repeat culture positivity within seven days as clinical outcome.
Correlation of quorum-sensing-related phenotypes with antimicrobial resistance burden among Pseudomonas aeruginosa, using routine phenotypic tests and susceptibility profiles assessed after isolate characterization.
Association of biofilm formation and pigment production among Pseudomonas aeruginosa isolates from device-associated infections, using microtitre plate assay and routine colony assessment.
Comparative expression of readily measurable quorum-sensing-related phenotypes among mucoid and non-mucoid Pseudomonas aeruginosa isolates, with biofilm strength assessed after incubation.
Immune Evasion
Association of capsule-associated mucoid phenotype with bloodstream infection among Klebsiella pneumoniae, using non-bloodstream isolates as comparator and clinical source assessed at final reporting.
Association of hypermucoviscous phenotype with neutrophil count abnormalities among Klebsiella pneumoniae infections, using routine string testing and blood counts obtained within twenty-four hours.
Association of methicillin resistance with neutrophilic response among Staphylococcus aureus infections, using cefoxitin testing and complete blood counts obtained within twenty-four hours.
Association of capsule-associated phenotype with biofilm formation among Klebsiella pneumoniae, using colony morphology and microtitre plate assay with outcomes assessed after characterization.
Association of persistent bacteraemia with biofilm-forming Staphylococcus aureus, using microtitre plate assay and repeat blood culture positivity within seven days.
Association of multidrug resistance with persistent bloodstream infection among Klebsiella pneumoniae, using routine susceptibility testing and repeat culture positivity within seven days.
Association of immune-evasion-associated virulence genes with invasive infection among Staphylococcus aureus where routine polymerase chain reaction exists, using non-invasive isolates as comparator.
Association of selected capsule-related genes with invasive Klebsiella pneumoniae infection where routine molecular testing exists, using non-invasive isolates as comparator.
Correlation of bacterial biofilm phenotype with reduced inflammatory-cell abundance in chronic wound specimens, using microtitre plate assay and direct microscopy from the same episode.
Association of recurrent infection with strong biofilm phenotype among device-associated bacterial isolates, using microtitre plate assay and recurrence documented within six months.
Intracellular Survival
Association of clinical severity with culture-confirmed Salmonella Typhi bloodstream infection, using routine culture and inflammatory markers measured within twenty-four hours of positivity: an observational study.
Association of antimicrobial resistance with prolonged fever in culture-confirmed Salmonella Typhi infection, using routine susceptibility testing and fever duration documented during admission.
Association of blood culture time to positivity with disease severity in Salmonella Typhi infection, using automated culture and discharge outcomes assessed during the same admission.
Association of intracellular-pathogen serology titres with clinical severity in scrub typhus, using routine immunoglobulin M testing and organ dysfunction documented during admission.
Association of scrub typhus seropositivity with thrombocytopenia among acute febrile illness patients, using routine serology and platelet counts obtained within twenty-four hours.
Association of leptospiral seropositivity with renal dysfunction among acute febrile illness patients, using routine serology and renal parameters measured during admission.
Comparative clinical-laboratory profiles of scrub typhus and leptospirosis among serologically confirmed patients, using routine serology and discharge outcomes assessed during the same admission.
Association of intracellular bacterial infection with inflammatory-marker elevation among culture- or serology-confirmed cases, using routine laboratory values measured within twenty-four hours.
Association of delayed diagnosis with complications in scrub typhus, using routine serological confirmation and time from admission to diagnosis compared with discharge outcomes.
Retrospective surveillance of laboratory-confirmed intracellular bacterial infections presenting as acute febrile illness, using routine records and seasonal distribution assessed over two years.
Host Inflammatory Response
Correlation of C-reactive protein with blood culture positivity among adults evaluated for sepsis, using culture as reference and biomarker values obtained within twenty-four hours.
Correlation of procalcitonin with blood culture positivity among adults evaluated for sepsis where routinely tested, using culture as reference and values obtained within twenty-four hours.
Comparative inflammatory-marker profiles in Gram-positive and Gram-negative bloodstream infections, using final culture identification and values measured within twenty-four hours of positivity.
Association of neutrophil-to-lymphocyte ratio with bloodstream infection mortality, using culture-confirmed cases and complete blood counts obtained within twenty-four hours with outcome at discharge.
Association of thrombocytopenia with mortality among adults with Gram-negative sepsis, using culture-confirmed infection and platelet counts obtained within twenty-four hours.
Correlation of blood culture time to positivity with C-reactive protein among monomicrobial bloodstream infections, using routine automated culture and biomarker values obtained within twenty-four hours.
Correlation of bacterial species with leucocyte-response patterns among bloodstream infections, using final culture identification and complete blood counts obtained within twenty-four hours.
Association of multidrug resistance with inflammatory-marker elevation among Gram-negative bloodstream infections, using susceptibility testing and laboratory values obtained within twenty-four hours.
Association of strong biofilm formation with inflammatory-marker levels among Staphylococcus aureus infections, using microtitre plate assay and routine blood tests obtained during the index episode.
Association of inflammatory-marker profiles with discharge outcome among culture-confirmed bacterial sepsis, using routine laboratory values within twenty-four hours and mortality assessed at discharge.
Immunology
Innate Immunity
Correlation of absolute neutrophil count with blood culture positivity among adults evaluated for sepsis, using culture as reference and counts obtained within twenty-four hours.
Association of neutropenia with bloodstream infection organism distribution among hospitalised patients, using routine blood cultures and neutrophil counts obtained within twenty-four hours.
Association of neutrophilia with Gram-positive versus Gram-negative bacteraemia, using final blood culture identification and complete blood counts obtained within twenty-four hours.
Correlation of neutrophil-to-lymphocyte ratio with culture positivity among suspected bacterial sepsis, using blood culture as reference and ratio calculated within twenty-four hours.
Association of neutrophil-to-lymphocyte ratio with mortality among culture-confirmed sepsis, using admission blood counts and discharge outcome during the same hospitalisation.
Association of phagocyte-count abnormalities with bacterial infection among chemotherapy patients, using culture-confirmed infection and blood counts obtained during the same febrile episode.
Association of complement component levels with recurrent bacterial infection among patients undergoing routine immunological evaluation, using laboratory records and infection frequency documented over six months.
Comparison of complement component levels among patients with and without recurrent encapsulated bacterial infections, using routine nephelometric testing and six-month clinical records.
Association of low complement levels with culture-confirmed infection in patients with autoimmune disease, using normal complement levels as comparator and infection outcomes assessed during admission.
Correlation of C-reactive protein with complement levels among patients with culture-confirmed bacterial infection, using routine assays obtained within twenty-four hours.
Association of interleukin measurements routinely available in selected patients with culture-confirmed sepsis severity, using laboratory values and organ-support requirement during admission.
Correlation of routinely measured cytokine markers with blood culture time to positivity in sepsis, using automated culture and samples obtained within twenty-four hours where clinically ordered.
Association of elevated inflammatory cytokine levels with mortality in culture-confirmed sepsis where routinely tested, using values obtained within twenty-four hours and outcome at discharge.
Comparative cytokine profiles of Gram-positive and Gram-negative bacteraemia where routine testing is available, using final culture identification and measurements obtained within twenty-four hours.
Association of pattern-recognition receptor-related routine inflammatory markers with bacterial culture positivity, using clinically ordered laboratory values and final culture results during the same episode.
Correlation of monocyte counts with blood culture positivity among adults with suspected sepsis, using final culture result and counts obtained within twenty-four hours.
Association of lymphopenia with culture-confirmed bacterial sepsis, using culture-negative suspected sepsis as comparator and blood counts obtained within twenty-four hours.
Association of thrombocytopenia with Gram-negative bloodstream infection, using Gram-positive bacteraemia as comparator and platelet counts obtained within twenty-four hours.
Association of leucocyte morphological changes on peripheral smear with culture-confirmed sepsis, using culture-negative suspected sepsis as comparator and smears reviewed within twenty-four hours.
Diagnostic performance of selected routine haematological markers for predicting blood culture positivity in suspected sepsis, using culture as reference and values obtained within twenty-four hours.
Adaptive Immunity
Association of absolute lymphocyte count with culture-confirmed infection among hospitalised adults, using culture-negative patients as comparator and counts obtained within twenty-four hours.
Association of lymphopenia with mortality among culture-confirmed sepsis patients, using admission blood counts and discharge outcome during the same hospitalisation.
Comparative lymphocyte-count patterns in bacterial and viral laboratory-confirmed infections, using routine microbiological diagnosis and blood counts obtained within twenty-four hours.
Association of CD4-positive T-lymphocyte counts with opportunistic infection spectrum among human immunodeficiency virus-infected adults, using routine records and infections diagnosed during admission.
Correlation of CD4-positive T-lymphocyte count with tuberculosis occurrence among human immunodeficiency virus-infected adults, using microbiologically confirmed tuberculosis and counts measured within thirty days.
Association of CD4-positive T-lymphocyte count with candidiasis among human immunodeficiency virus-infected adults, using laboratory-confirmed infection and counts measured within thirty days.
Association of CD4-positive T-lymphocyte count with cryptococcal antigen positivity among human immunodeficiency virus-infected adults, using routine antigen testing and counts measured within thirty days.
Distribution of opportunistic infections across CD4-positive T-lymphocyte count categories among human immunodeficiency virus-infected adults, using routine microbiology records from the same admission.
Association of hepatitis B surface antibody levels with documented vaccination history among healthcare workers, using routine serology and vaccination records assessed at enrollment.
Proportion of healthcare workers with protective hepatitis B surface antibody levels after documented vaccination, using routine quantitative serology and vaccination records assessed cross-sectionally.
Association of time since hepatitis B vaccination with protective antibody levels among healthcare workers, using routine serology and documented vaccination dates.
Association of booster vaccination history with hepatitis B surface antibody levels among previously vaccinated healthcare workers, using routine serology and records assessed cross-sectionally.
Comparative antibody response to hepatitis B vaccination among healthcare workers with and without documented complete primary vaccination, using quantitative serology at enrollment.
Association of age with hepatitis B surface antibody levels among fully vaccinated healthcare workers, using routine quantitative serology and vaccination records assessed cross-sectionally.
Association of diabetes mellitus with hepatitis B surface antibody levels among fully vaccinated healthcare workers, using routine serology and clinical records assessed cross-sectionally.
Correlation of antibody titres with time since documented vaccination among healthcare workers, using routine quantitative hepatitis B surface antibody testing at enrollment.
Seroprevalence of protective hepatitis B surface antibodies among medical residents, using quantitative serology and documented vaccination status assessed during the study visit.
Association of incomplete hepatitis B vaccination with non-protective antibody levels among healthcare workers, using quantitative serology and documented vaccine history assessed cross-sectionally.
Hypersensitivity
Association of total immunoglobulin E levels with laboratory-confirmed fungal sensitization among patients undergoing routine allergy evaluation, using specific immunoglobulin E results and values assessed at the same visit.
Correlation of eosinophil count with total immunoglobulin E among patients with suspected immediate hypersensitivity, using routine laboratory tests obtained during the same evaluation.
Association of elevated total immunoglobulin E with recurrent allergic symptoms among patients undergoing routine immunological testing, using clinical records from the preceding six months.
Agreement between skin-prick testing and serum-specific immunoglobulin E for selected allergens where both are clinically performed, with concordance assessed during the same evaluation.
Association of eosinophilia with positive allergen-specific immunoglobulin E among patients with suspected immediate hypersensitivity, using routine tests obtained during the same visit.
Association of drug-dependent antibody testing with clinical history in suspected immune-mediated haemolytic reactions where routinely performed, using adjudicated clinical diagnosis as comparator.
Agreement between direct antiglobulin testing and clinical evidence of immune-mediated haemolysis, using routine laboratory parameters and outcomes assessed during the same episode.
Association of positive direct antiglobulin tests with transfusion history among hospitalised patients, using negative tests as comparator and exposure assessed during the preceding three months.
Laboratory profile of suspected immune-complex-mediated reactions among patients undergoing complement testing, using complement levels and inflammatory markers obtained during the same episode.
Association of low complement levels with clinically suspected immune-complex disease, using normal complement results as comparator and diagnosis recorded at discharge.
Association of interferon-gamma release assay positivity with delayed-type hypersensitivity evidence in tuberculosis contacts where routinely tested, using clinical evaluation during the same episode.
Agreement between tuberculin skin testing and interferon-gamma release assay among healthcare workers where both are routinely performed, with concordance assessed within thirty days.
Autoimmunity
Agreement between antinuclear antibody screening by immunofluorescence and automated immunoassay among patients undergoing autoimmune evaluation, with concordance assessed on the same serum sample.
Association of antinuclear antibody patterns with specific autoantibody profiles, using routine immunofluorescence and immunoassays performed during the same diagnostic evaluation.
Diagnostic performance of antinuclear antibody screening for selected connective-tissue disorders, using final rheumatology diagnosis as reference and results assessed during the index evaluation.
Association of antinuclear antibody titre with specific autoantibody positivity, using routine immunofluorescence and immunoassays performed on the same serum sample.
Agreement between two routinely available methods for rheumatoid factor detection, using clinical diagnosis as reference and concordance assessed during the same evaluation.
Association of rheumatoid factor positivity with anti-citrullinated protein antibody positivity, using routine serology and results obtained during the same diagnostic episode.
Agreement between indirect immunofluorescence and immunoassay for selected autoimmune antibodies, using clinical diagnosis as reference and concordance assessed during the same evaluation.
Frequency of incidental autoantibody positivity among patients tested for suspected autoimmune disease, using final clinical diagnosis and serology results assessed at discharge or follow-up.
Association of autoantibody positivity with complement consumption among patients with systemic autoimmune disease, using routine serology and complement levels obtained during the same visit.
Retrospective audit of autoimmune serology ordering and diagnostic yield, using laboratory records and final clinical diagnoses assessed over a twelve-month period.
Immunodeficiency
Spectrum of microbiologically confirmed infections among patients with primary immunodeficiency attending a teaching hospital, using routine culture and serology records with outcomes assessed during admission.
Association of immunoglobulin levels with infection frequency among patients evaluated for primary immunodeficiency, using routine laboratory records and infections documented over six months.
Association of lymphocyte subset abnormalities with opportunistic infections among patients with primary immunodeficiency, using routine flow-cytometry and microbiology records from the same period.
Distribution of bacterial, fungal, and viral infections among patients with primary immunodeficiency, using routine microbiological diagnosis and clinical outcomes assessed during admission.
Spectrum of microbiologically confirmed infections among patients with secondary immunodeficiency, using routine laboratory records and discharge outcomes assessed during admission.
Association of corticosteroid exposure with opportunistic infection among hospitalised adults, using unexposed patients as comparator and medication exposure assessed during the preceding ninety days.
Association of neutropenia duration with bloodstream infection among chemotherapy patients, using culture results and neutrophil counts monitored during the same admission.
Association of low CD4-positive T-lymphocyte count with opportunistic infection among human immunodeficiency virus-infected adults, using routine counts and infections diagnosed during admission.
Association of diabetes mellitus with mucormycosis among patients evaluated for invasive mould infection, using non-mucormycosis mould infections as comparator and clinical records at diagnosis.
Association of uncontrolled blood glucose with candiduria among hospitalised adults, using culture-negative diabetic patients as comparator and glucose measurements obtained within forty-eight hours.
Tumour Immunology
Association of neutropenia with bloodstream infection among patients receiving chemotherapy for haematological malignancy, using blood culture and neutrophil counts obtained during the same febrile episode.
Spectrum of bloodstream pathogens among patients with haematological malignancy, using automated blood culture and antimicrobial susceptibility results assessed during the same admission.
Association of prolonged neutropenia with invasive fungal infection among haematological malignancy patients, using routine mycology results and neutrophil counts monitored during admission.
Association of lymphocyte-count abnormalities with viral reactivation detected by routine molecular testing among oncology patients, with laboratory results assessed during the same admission.
Retrospective surveillance of microbiologically confirmed infections among oncology patients, using laboratory records and infection distribution assessed across twelve months.
Transplant Immunology
Spectrum of microbiologically confirmed infections among renal transplant recipients, using routine culture and molecular diagnostics with infection timing assessed within six months after transplantation.
Association of immunosuppressive regimen intensity with culture-confirmed infection among renal transplant recipients, using routine clinical records and infections documented within six months.
Spectrum of urinary pathogens and antimicrobial resistance among renal transplant recipients, using routine urine cultures and susceptibility results assessed during the same episode.
Association of lymphocyte counts with opportunistic infection among solid-organ transplant recipients, using routine haematology and microbiology records obtained during the same admission.
Retrospective surveillance of bacterial, fungal, and viral infections among transplant recipients, using routine laboratory records and infection timing assessed within six months after transplantation.
Serology and Immunodiagnostics
Agglutination Tests
Diagnostic accuracy of Widal agglutination testing for suspected enteric fever, using blood culture as reference and sensitivity and specificity assessed during the acute febrile episode.
Agreement between slide and tube Widal agglutination tests in suspected enteric fever, using blood culture as reference and concordance assessed during the same episode.
Association of Widal agglutination titres with blood culture positivity among suspected enteric fever patients, using samples obtained during the first week of illness.
Diagnostic yield of Widal agglutination testing by day of illness in suspected enteric fever, using blood culture as reference and performance assessed during the acute episode.
Frequency of isolated agglutinin elevation among culture-negative febrile patients, using blood culture and final clinical diagnosis as comparators during the same admission.
Diagnostic accuracy of latex agglutination antigen testing in cerebrospinal fluid where routinely used, using culture as reference and performance assessed at final microbiology reporting.
Agreement between latex agglutination and culture for selected bacterial antigens in cerebrospinal fluid, with concordance assessed during the same meningitis episode.
Diagnostic accuracy of cryptococcal latex agglutination in cerebrospinal fluid where routinely available, using culture or lateral-flow antigen testing as reference and performance assessed during admission.
Agreement between rheumatoid factor agglutination testing and quantitative immunoassay, using clinical diagnosis as reference and concordance assessed during the same evaluation.
Agreement between C-reactive protein latex agglutination and quantitative immunoassay where both are used, with concordance assessed on the same serum sample.
Inter-observer agreement in reading weak agglutination reactions for routine serological tests, using consensus interpretation as reference and kappa assessed prospectively.
Audit of agglutination-test quality-control performance in a teaching hospital laboratory, using daily control records and failure frequency assessed over six months.
ELISA
Diagnostic accuracy of enzyme linked immunosorbent assay for dengue immunoglobulin M in acute febrile illness, using composite clinical and laboratory diagnosis as reference and performance assessed during admission.
Association of dengue immunoglobulin M positivity by enzyme linked immunosorbent assay with day of illness, using acute serum samples and positivity proportions assessed during the same episode.
Diagnostic accuracy of dengue non-structural protein one antigen enzyme linked immunosorbent assay, using routine molecular or composite diagnosis as reference and performance assessed in early illness.
Agreement between dengue non-structural protein one antigen enzyme linked immunosorbent assay and rapid immunochromatographic testing, with concordance assessed on the same acute serum sample.
Diagnostic accuracy of scrub typhus immunoglobulin M enzyme linked immunosorbent assay among acute febrile illness patients, using composite clinical diagnosis as reference and performance assessed during admission.
Association of scrub typhus immunoglobulin M optical density with clinical severity, using routine enzyme linked immunosorbent assay and organ dysfunction assessed during the same admission.
Diagnostic accuracy of leptospira immunoglobulin M enzyme linked immunosorbent assay among acute febrile illness patients, using composite clinical diagnosis as reference and performance assessed during admission.
Association of leptospira immunoglobulin M positivity with renal and hepatic dysfunction, using routine enzyme linked immunosorbent assay and laboratory parameters obtained during admission.
Agreement between enzyme linked immunosorbent assay and rapid testing for hepatitis B surface antigen, with concordance assessed on the same serum sample.
Agreement between enzyme linked immunosorbent assay and rapid testing for hepatitis C antibodies, with concordance assessed on the same serum sample.
Diagnostic performance of enzyme linked immunosorbent assay for human immunodeficiency virus antibodies compared with the routine national testing algorithm, with concordance assessed during the same evaluation.
Association of hepatitis B surface antibody levels measured by enzyme linked immunosorbent assay with vaccination history among healthcare workers, using documented vaccine records at enrollment.
Seroprevalence of hepatitis C antibodies among selected high-risk hospital attendees using enzyme linked immunosorbent assay, with risk factors documented at the same visit.
Seroprevalence of scrub typhus antibodies among acute febrile illness patients using enzyme linked immunosorbent assay, with seasonal distribution assessed over one year.
Seroprevalence of leptospira antibodies among acute febrile illness patients using enzyme linked immunosorbent assay, with seasonal distribution assessed over one year.
Inter-run precision of routine enzyme linked immunosorbent assays for infectious disease serology, using internal control optical densities and coefficient of variation assessed over six months.
CLIA
Agreement between chemiluminescent immunoassay and enzyme linked immunosorbent assay for hepatitis B surface antigen, with concordance assessed on the same serum specimens.
Agreement between chemiluminescent immunoassay and enzyme linked immunosorbent assay for hepatitis C antibodies, with concordance assessed on the same serum specimens.
Agreement between chemiluminescent immunoassay and routine rapid testing for human immunodeficiency virus screening, using the national testing algorithm as reference and concordance assessed same day.
Diagnostic performance of chemiluminescent immunoassay for hepatitis B surface antigen, using the routine confirmatory algorithm as reference and sensitivity assessed during the same evaluation.
Diagnostic performance of chemiluminescent immunoassay for hepatitis C antibodies, using supplemental testing as reference and sensitivity assessed during the same diagnostic episode.
Association of signal-to-cutoff ratios in chemiluminescent hepatitis C antibody testing with supplemental positivity, using routine confirmatory testing and results assessed during the same episode.
Association of signal-to-cutoff ratios in chemiluminescent hepatitis B surface antigen testing with confirmatory positivity, using routine neutralization where available and results assessed same day.
Frequency and resolution of borderline chemiluminescent immunoassay results in infectious disease screening, using repeat testing and final algorithmic classification within forty-eight hours.
Comparative turnaround time of chemiluminescent immunoassay and enzyme linked immunosorbent assay for routine infectious serology, with time from receipt to verification measured prospectively.
Audit of internal quality-control performance for infectious disease chemiluminescent immunoassays, using daily control data and failure rates assessed over six months.
Immunofluorescence
Agreement between indirect immunofluorescence and enzyme immunoassay for antinuclear antibody screening, using final clinical diagnosis as reference and concordance assessed during the same evaluation.
Association of antinuclear antibody immunofluorescence patterns with specific autoantibody profiles, using routine immunoassays performed on the same serum samples.
Inter-observer agreement in antinuclear antibody pattern interpretation by indirect immunofluorescence, using expert consensus as reference and kappa assessed prospectively.
Inter-observer agreement in antinuclear antibody endpoint titre interpretation, using expert consensus as reference and reproducibility assessed on the same sample set.
Diagnostic performance of selected immunofluorescence patterns for systemic autoimmune disease, using rheumatology diagnosis as reference and results assessed at completion of evaluation.
Agreement between manual and automated immunofluorescence image interpretation where available, using expert review as reference and concordance assessed on the same slides.
Frequency of incidental low-titre antinuclear antibody positivity among patients undergoing routine testing, using final clinical diagnosis and results assessed during the same evaluation.
Audit of immunofluorescence quality-control and slide-reading documentation, using departmental standards and compliance assessed over six months.
Immunoblotting
Agreement between immunoblot confirmation and screening immunoassay for selected infectious disease antibodies, with concordance assessed during the same diagnostic episode.
Diagnostic yield of immunoblotting among repeatedly reactive hepatitis C antibody screening samples, using supplemental molecular testing where available and final classification assessed after testing.
Diagnostic yield of immunoblotting in selected autoimmune antibody profiles where routinely available, using final specialist diagnosis as reference and concordance assessed after evaluation.
Association of immunoblot band patterns with specific autoimmune diagnoses, using routine clinical classification and results assessed during the same diagnostic episode.
Frequency of indeterminate immunoblot results and their resolution on repeat testing, using the routine diagnostic algorithm and final classification assessed within thirty days.
Comparative turnaround time of immunoblotting and alternative supplemental immunoassays where available, with time to final verified result measured prospectively.
Rapid Immunochromatographic Tests
Diagnostic accuracy of rapid dengue non-structural protein one antigen testing in early febrile illness, using enzyme linked immunosorbent assay as reference and performance assessed during admission.
Agreement between rapid dengue immunoglobulin M testing and enzyme linked immunosorbent assay, with concordance assessed according to day of illness on paired serum testing.
Diagnostic accuracy of rapid malaria antigen testing among febrile patients, using peripheral blood microscopy as reference and sensitivity and specificity assessed on the same specimen.
Agreement between rapid malaria antigen testing and peripheral smear microscopy for Plasmodium falciparum and Plasmodium vivax, with species concordance assessed during acute presentation.
Diagnostic accuracy of rapid hepatitis B surface antigen testing, using chemiluminescent immunoassay or enzyme linked immunosorbent assay as reference and performance assessed same day.
Diagnostic accuracy of rapid hepatitis C antibody testing, using chemiluminescent immunoassay or enzyme linked immunosorbent assay as reference and performance assessed same day.
Agreement between two routinely used rapid human immunodeficiency virus antibody tests, using the national testing algorithm as reference and concordance assessed during the same visit.
Diagnostic accuracy of scrub typhus rapid antibody testing, using immunoglobulin M enzyme linked immunosorbent assay as reference and performance assessed during acute febrile illness.
Diagnostic accuracy of leptospira rapid antibody testing, using immunoglobulin M enzyme linked immunosorbent assay as reference and performance assessed during acute febrile illness.
Diagnostic accuracy of cryptococcal antigen lateral-flow testing in serum among high-risk patients, using cerebrospinal fluid testing or culture as reference and performance assessed during admission.
Diagnostic accuracy of cryptococcal antigen lateral-flow testing in cerebrospinal fluid, using culture or composite diagnosis as reference and performance assessed during admission.
Agreement between rapid and laboratory-based syphilis serological tests, using the routine confirmatory algorithm as reference and concordance assessed during the same episode.
Comparative turnaround time of rapid immunochromatographic and laboratory immunoassays for selected infectious diseases, with time from sample receipt to verified result measured prospectively.
Frequency and causes of invalid rapid immunochromatographic tests in routine diagnostics, using repeat testing as comparator and final valid-result rate assessed over six months.
Antigen Detection
Diagnostic accuracy of dengue non-structural protein one antigen detection among early febrile patients, using composite laboratory diagnosis as reference and performance assessed by day of illness.
Association of dengue non-structural protein one antigen positivity with thrombocytopenia, using routine antigen testing and platelet counts obtained during the same acute episode.
Diagnostic accuracy of cryptococcal antigen detection in serum among human immunodeficiency virus-infected adults, using cerebrospinal fluid evaluation or composite diagnosis as reference during admission.
Association of serum cryptococcal antigen titre with central nervous system involvement, using cerebrospinal fluid findings and clinical diagnosis assessed during the same admission.
Diagnostic accuracy of hepatitis B surface antigen rapid detection, using laboratory immunoassay as reference and sensitivity and specificity assessed on the same serum sample.
Agreement between two routinely available hepatitis B surface antigen assays, using confirmatory testing where required and concordance assessed on the same sample.
Diagnostic yield of stool antigen detection for selected enteric pathogens where routinely available, using culture as comparator and additional detections assessed during the same diarrhoeal episode.
Diagnostic accuracy of urinary antigen detection for selected infections where routinely available, using culture or composite diagnosis as reference and performance assessed during admission.
Diagnostic accuracy of bacterial antigen detection in cerebrospinal fluid where routinely performed, using culture as reference and sensitivity assessed at final microbiology reporting.
Association of antigen concentration or semi-quantitative intensity with disease severity in selected routine antigen assays, using clinical outcomes assessed during the same admission.
Comparative turnaround time of antigen detection and culture for selected infections, with time from specimen receipt to verified result measured prospectively.
Retrospective audit of positive antigen tests with negative reference investigations, using clinical records and final diagnostic classification assessed at discharge.
Antibody Detection
Diagnostic accuracy of scrub typhus immunoglobulin M antibody detection in acute febrile illness, using composite clinical diagnosis as reference and performance assessed during admission.
Association of scrub typhus immunoglobulin M positivity with thrombocytopenia and transaminitis, using routine serology and laboratory values obtained during the same admission.
Diagnostic accuracy of leptospira immunoglobulin M antibody detection in acute febrile illness, using composite diagnosis as reference and performance assessed during admission.
Association of leptospira immunoglobulin M positivity with acute kidney injury, using routine serology and renal parameters obtained during the same admission.
Diagnostic accuracy of dengue immunoglobulin M antibody detection, using composite laboratory diagnosis as reference and performance assessed according to day of illness.
Agreement between dengue immunoglobulin M rapid testing and enzyme linked immunosorbent assay, with concordance assessed on the same serum sample during acute illness.
Seroprevalence of hepatitis C antibodies among haemodialysis patients using routine immunoassay, with dialysis duration and transfusion history assessed at enrollment.
Association of hepatitis C antibody positivity with transfusion history among haemodialysis patients, using antibody-negative patients as comparator and exposure assessed from records.
Seroprevalence of hepatitis B antibodies among vaccinated healthcare workers, using quantitative immunoassay and documented vaccination history assessed cross-sectionally.
Association of protective hepatitis B antibody levels with time since vaccination among healthcare workers, using quantitative serology and documented vaccination dates.
Agreement between two routinely used antibody-detection platforms for selected infectious diseases, with concordance assessed on the same serum specimen.
Audit of equivocal infectious disease antibody results and their resolution, using repeat testing and final diagnostic classification within thirty days.
Microbial Biofilms
Biofilm Formation
Prevalence of biofilm formation among Escherichia coli urinary isolates using microtitre plate assay, with biofilm strength categorized after twenty-four hours: a laboratory-based cross-sectional study.
Prevalence of biofilm formation among Klebsiella pneumoniae clinical isolates using microtitre plate assay, with biofilm strength categorized after twenty-four hours: a cross-sectional study.
Prevalence of biofilm formation among Pseudomonas aeruginosa clinical isolates using microtitre plate assay, with biofilm strength categorized after twenty-four hours.
Prevalence of biofilm formation among Acinetobacter baumannii clinical isolates using microtitre plate assay, with biofilm strength categorized after twenty-four hours.
Prevalence of biofilm formation among Staphylococcus aureus wound isolates using microtitre plate assay, with biofilm strength categorized after twenty-four hours.
Prevalence of biofilm formation among coagulase-negative staphylococci from clinically significant blood cultures, using microtitre plate assay and biofilm categories assessed after incubation.
Prevalence of biofilm formation among Enterococcus species urinary isolates using microtitre plate assay, with biofilm strength categorized after twenty-four hours.
Comparative biofilm formation by Escherichia coli isolates from catheterized and non-catheterized patients, using microtitre plate assay and biofilm strength assessed after incubation.
Comparative biofilm formation by Klebsiella pneumoniae isolates from intensive-care and general-ward patients, using microtitre plate assay and strength assessed after twenty-four hours.
Comparative biofilm formation by Pseudomonas aeruginosa isolates from respiratory and wound specimens, using microtitre plate assay and strength assessed after incubation.
Association of mucoid phenotype with biofilm strength among Klebsiella pneumoniae, using colony morphology and microtitre plate assay assessed after twenty-four hours.
Association of pigment production with biofilm strength among Pseudomonas aeruginosa, using colony phenotype and microtitre plate assay assessed after twenty-four hours.
Association of methicillin resistance with biofilm formation among Staphylococcus aureus, using cefoxitin disc diffusion and microtitre plate assay assessed after isolate characterization.
Association of carbapenem resistance with biofilm formation among Klebsiella pneumoniae, using meropenem susceptibility and microtitre plate assay assessed concurrently.
Association of multidrug resistance with biofilm strength among Escherichia coli urinary isolates, using routine susceptibility testing and microtitre plate assay assessed after characterization.
Association of multidrug resistance with biofilm strength among Pseudomonas aeruginosa isolates, using routine susceptibility testing and microtitre plate assay assessed after characterization.
Biofilm Detection Methods
Agreement between microtitre plate assay and tube-adherence method for biofilm detection among Staphylococcus aureus isolates, with concordance assessed after twenty-four-hour incubation.
Agreement between microtitre plate assay and tube-adherence method for biofilm detection among Escherichia coli isolates, with concordance assessed after incubation.
Agreement between microtitre plate assay and Congo red agar method for biofilm detection among Staphylococcus aureus, with concordance assessed after routine incubation.
Agreement between microtitre plate assay and Congo red agar method for biofilm detection among coagulase-negative staphylococci, with concordance assessed after incubation.
Agreement between microtitre plate assay and Congo red agar method for biofilm detection among Klebsiella pneumoniae, with concordance assessed after incubation.
Diagnostic performance of tube-adherence testing for biofilm detection among Staphylococcus aureus, using microtitre plate assay as reference and sensitivity assessed after incubation.
Diagnostic performance of Congo red agar for biofilm detection among Staphylococcus aureus, using microtitre plate assay as reference and sensitivity assessed after incubation.
Diagnostic performance of Congo red agar for biofilm detection among coagulase-negative staphylococci, using microtitre plate assay as reference and sensitivity assessed after incubation.
Inter-observer agreement in visual tube-adherence biofilm grading among clinical isolates, using consensus interpretation as reference and kappa assessed after incubation.
Inter-observer agreement in Congo red agar colony interpretation for biofilm detection, using consensus interpretation and microtitre plate assay as comparators.
Reproducibility of microtitre plate biofilm quantification among Escherichia coli isolates, using duplicate assays and within-isolate variability assessed on repeat testing.
Reproducibility of microtitre plate biofilm quantification among Staphylococcus aureus isolates, using duplicate assays and within-isolate variability assessed on repeat testing.
Association of incubation duration with microtitre plate biofilm categorization among Pseudomonas aeruginosa, using standard twenty-four-hour incubation as comparator and category changes assessed.
Association of inoculum density with microtitre plate biofilm categorization among Klebsiella pneumoniae, using standardized inoculum as comparator and category changes assessed after incubation.
Comparative biofilm detection using polystyrene microtitre plates from two routinely available sources, with categorical agreement assessed among common clinical isolates.
Audit of internal quality control for microtitre plate biofilm assays, using reference control strains and reproducibility outcomes assessed over six months.
Biofilm in Medical Devices
Association of biofilm formation with catheter-associated urinary tract infection among Escherichia coli, using microtitre plate assay and non-catheter urinary isolates as comparator.
Association of biofilm formation with catheter-associated urinary tract infection among Klebsiella pneumoniae, using microtitre plate assay and non-catheter urinary isolates as comparator.
Association of biofilm formation with central-line-associated bloodstream infection among coagulase-negative staphylococci, using microtitre plate assay and non-device bloodstream isolates as comparator.
Association of biofilm formation with central-line-associated bloodstream infection among Staphylococcus aureus, using microtitre plate assay and non-device bloodstream isolates as comparator.
Association of biofilm formation with ventilator-associated respiratory infection among Pseudomonas aeruginosa, using microtitre plate assay and non-ventilated respiratory isolates as comparator.
Association of biofilm formation with ventilator-associated respiratory infection among Acinetobacter baumannii, using microtitre plate assay and non-ventilated respiratory isolates as comparator.
Comparative biofilm strength of device-associated and non-device-associated Enterococcus isolates, using microtitre plate assay and biofilm categories assessed after incubation.
Comparative biofilm strength of catheter-associated and community urinary Escherichia coli isolates, using microtitre plate assay and categories assessed after twenty-four hours.
Association of catheter duration with strong biofilm-forming urinary isolates, using microtitre plate assay and device-days documented at specimen collection.
Association of central-line duration with strong biofilm-producing bloodstream isolates, using microtitre plate assay and device-days documented before culture positivity.
Association of mechanical ventilation duration with strong biofilm-producing respiratory isolates, using microtitre plate assay and ventilation days documented before culture positivity.
Association of urinary catheter biofilm-producing organisms with recurrent bacteriuria, using microtitre plate assay and repeat culture positivity within thirty days.
Association of device-associated biofilm-producing organisms with multidrug resistance, using microtitre plate assay and routine susceptibility testing assessed after characterization.
Association of biofilm strength with device removal among bloodstream infections, using microtitre plate assay and device-management decisions documented during admission.
Association of strong biofilm formation with persistent device-associated bacteraemia, using microtitre plate assay and repeat blood culture positivity within seven days.
Spectrum and resistance profile of biofilm-forming organisms from device-associated infections, using microtitre plate assay and routine susceptibility results assessed at final reporting.
Biofilm and Antimicrobial Resistance
Correlation of biofilm strength with multidrug resistance among Escherichia coli urinary isolates, using microtitre plate assay and routine susceptibility testing assessed concurrently.
Correlation of biofilm strength with multidrug resistance among Klebsiella pneumoniae isolates, using microtitre plate assay and routine susceptibility testing assessed concurrently.
Correlation of biofilm strength with multidrug resistance among Pseudomonas aeruginosa isolates, using microtitre plate assay and routine susceptibility testing assessed concurrently.
Correlation of biofilm strength with multidrug resistance among Acinetobacter baumannii isolates, using microtitre plate assay and routine susceptibility testing assessed concurrently.
Association of strong biofilm formation with methicillin resistance among Staphylococcus aureus, using microtitre plate assay and cefoxitin disc diffusion assessed concurrently.
Association of strong biofilm formation with inducible clindamycin resistance among Staphylococcus aureus, using microtitre plate assay and disc approximation testing assessed concurrently.
Association of strong biofilm formation with high-level aminoglycoside resistance among Enterococcus species, using microtitre plate assay and routine susceptibility testing assessed concurrently.
Association of biofilm strength with carbapenemase production among Klebsiella pneumoniae, using microtitre plate assay and phenotypic carbapenemase testing assessed after characterization.
Association of biofilm strength with extended spectrum beta lactamase production among Escherichia coli, using microtitre plate assay and phenotypic confirmation assessed concurrently.
Association of biofilm strength with AmpC beta lactamase production among Enterobacterales, using microtitre plate assay and phenotypic confirmatory testing assessed after characterization.
Comparative susceptibility profiles of strong and weak biofilm-producing Escherichia coli, using microtitre plate classification and routine disc diffusion assessed at final reporting.
Comparative susceptibility profiles of strong and weak biofilm-producing Klebsiella pneumoniae, using microtitre plate classification and routine susceptibility testing assessed at final reporting.
Comparative susceptibility profiles of strong and weak biofilm-producing Pseudomonas aeruginosa, using microtitre plate classification and routine susceptibility testing assessed at final reporting.
Comparative susceptibility profiles of strong and weak biofilm-producing Staphylococcus aureus, using microtitre plate classification and routine susceptibility testing assessed at final reporting.
Association of biofilm strength with vancomycin minimum inhibitory concentration among Staphylococcus aureus, using microtitre plate assay and broth microdilution assessed after characterization.
Association of biofilm strength with meropenem minimum inhibitory concentration among Klebsiella pneumoniae, using microtitre plate assay and broth microdilution assessed after characterization.
Biofilm-Associated Hospital Infections
Association of strong biofilm formation with hospital-acquired urinary tract infection among Escherichia coli, using microtitre plate assay and community-acquired infections as comparator.
Association of strong biofilm formation with hospital-acquired urinary tract infection among Klebsiella pneumoniae, using microtitre plate assay and community-acquired infections as comparator.
Association of strong biofilm formation with hospital-acquired bloodstream infection among Staphylococcus aureus, using microtitre plate assay and community-onset infections as comparator.
Association of strong biofilm formation with hospital-acquired respiratory infection among Pseudomonas aeruginosa, using microtitre plate assay and community-onset infections as comparator.
Association of strong biofilm formation with hospital-acquired respiratory infection among Acinetobacter baumannii, using microtitre plate assay and non-hospital-acquired isolates as comparator.
Association of strong biofilm formation with surgical site infection among Staphylococcus aureus, using microtitre plate assay and wound-isolate clinical classification during admission.
Association of strong biofilm formation with intensive-care acquisition among Klebsiella pneumoniae, using microtitre plate assay and general-ward isolates as comparator.
Association of strong biofilm formation with intensive-care acquisition among Acinetobacter baumannii, using microtitre plate assay and general-ward isolates as comparator.
Association of biofilm-producing hospital pathogens with prolonged length of stay, using non-biofilm-producing isolates as comparator and stay measured until discharge.
Association of biofilm-producing hospital pathogens with in-hospital mortality, using non-biofilm-producing isolates as comparator and outcome assessed at discharge.
Association of biofilm-producing bloodstream isolates with persistent bacteraemia, using non-biofilm-producing isolates as comparator and repeat culture positivity within seven days.
Association of biofilm-producing urinary isolates with recurrent bacteriuria, using non-biofilm-producing isolates as comparator and repeat positivity within thirty days.
Association of biofilm-producing hospital isolates with prior antibiotic exposure, using non-biofilm-producing isolates as comparator and exposure assessed during the preceding ninety days.
Association of biofilm-producing hospital isolates with invasive-device exposure, using non-biofilm-producing isolates as comparator and device status assessed before culture positivity.
Ward-wise distribution of strong biofilm-producing bacterial isolates in a teaching hospital, using microtitre plate assay and location at specimen collection assessed over twelve months.
Retrospective surveillance of biofilm-associated healthcare infections using stored isolates and clinical records, with organism distribution and outcomes assessed over twelve months.
Microbiome and Human Microbial Ecology
Gut Microbiome
Culture-based comparison of predominant aerobic gut bacteria among hospitalised adults before and after broad-spectrum antibiotic exposure, with community composition assessed within seven days: a prospective observational study.
Association of recent antibiotic exposure with intestinal colonization by multidrug-resistant Enterobacterales, using routine rectal or stool cultures obtained with consent and exposure assessed over ninety days.
Prevalence of intestinal colonization by carbapenem-resistant Enterobacterales among high-risk inpatients, using consented rectal swabs and colonization status assessed at enrollment.
Association of intestinal carriage of multidrug-resistant Enterobacterales with subsequent clinical infection, using consented screening cultures and infection occurrence assessed during the same admission.
Comparative culture-based gut bacterial profiles of patients with and without antibiotic-associated diarrhoea, using stool cultures and clinical classification during the same episode.
Association of prolonged hospitalisation with intestinal carriage of resistant Enterobacterales, using consented screening cultures and length of stay before sampling assessed at enrollment.
Respiratory Microbiome
Culture-based comparison of upper respiratory bacterial colonization among ventilated and non-ventilated intensive-care patients, using routine or consented non-invasive samples and colonization assessed at enrollment.
Association of upper respiratory colonization with subsequent ventilator-associated infection, using consented respiratory screening cultures and infection occurrence assessed during the same admission.
Comparative culture-based respiratory colonization patterns in intensive-care and general-ward patients, using non-invasive specimens and organism distribution assessed at enrollment.
Association of prior antibiotic exposure with respiratory colonization by multidrug-resistant Gram-negative bacilli, using consented specimens and exposure assessed over the preceding ninety days.
Association of respiratory colonization by carbapenem-resistant Gram-negative bacilli with subsequent clinical infection, using screening cultures and infection occurrence assessed during admission.
Culture-based characterization of oral-respiratory bacterial overlap among mechanically ventilated patients, using paired non-invasive specimens and organism concordance assessed on the same day.
Vaginal Microbiome
Culture-based characterization of vaginal bacterial and yeast flora among symptomatic reproductive-age women, using clinician-collected specimens and organism distribution assessed at final laboratory reporting.
Association of vaginal Lactobacillus depletion with bacterial vaginosis among symptomatic women, using microscopy-based reference criteria and culture findings assessed during the same visit.
Agreement between Gram-stain scoring and clinical criteria for bacterial vaginosis, using symptomatic women and concordance assessed on specimens obtained during the same examination.
Association of vaginal Candida colonization with diabetes mellitus among symptomatic women, using fungal culture and clinical records assessed during the same episode.
Comparative vaginal culture profiles of pregnant and non-pregnant symptomatic women, using routine specimens and organism distribution assessed at final reporting.
Association of recent antibiotic exposure with vaginal candidiasis, using culture-confirmed cases and culture-negative symptomatic women as comparator with exposure assessed over ninety days.
Oral Microbiome
Culture-based comparison of oral bacterial carriage among diabetic and non-diabetic adults, using non-invasive oral swabs and organism distribution assessed at enrollment.
Association of poor glycaemic control with oral Candida colonization, using non-invasive oral cultures and glycated haemoglobin results obtained within three months.
Comparative oral Candida carriage among denture users and non-users, using non-invasive oral swabs and culture positivity assessed at enrollment.
Association of recent antibiotic exposure with oral Candida colonization, using non-invasive oral cultures and exposure assessed over the preceding ninety days.
Comparative culture-based oral microbial profiles among smokers and non-smokers attending routine care, using oral swabs and organism distribution assessed at enrollment.
Association of oral colonization with respiratory pathogens among hospitalised adults, using non-invasive oral cultures and subsequent respiratory culture positivity assessed during admission.
Skin Microbiome
Culture-based comparison of skin bacterial carriage among healthcare workers from intensive-care and general wards, using consented hand swabs and organism distribution assessed at enrollment.
Prevalence of Staphylococcus aureus hand carriage among healthcare workers, using consented hand cultures and antimicrobial susceptibility profiles assessed at final reporting.
Association of frequent hand-sanitizer use with recoverable skin bacterial counts among healthcare workers, using consented hand cultures and use frequency assessed by questionnaire.
Comparative bacterial carriage on dominant and non-dominant hands of healthcare workers, using paired consented cultures and colony counts assessed on the same day.
Association of glove use duration with hand bacterial counts among healthcare workers, using pre- and post-duty consented cultures and counts assessed during the same shift.
Dysbiosis
Association of recent broad-spectrum antibiotic exposure with culture-defined intestinal dysbiosis among hospitalised adults, using stool culture profiles and exposure assessed over ninety days.
Association of antibiotic exposure duration with reduced gut bacterial diversity by routine culture, using stool specimens and exposure documented during the same admission.
Association of diabetes mellitus with culture-defined vaginal dysbiosis among symptomatic women, using routine vaginal cultures and clinical records assessed at the same visit.
Association of proton-pump inhibitor exposure with culture-defined upper gastrointestinal microbial changes where specimens are clinically obtained, using unexposed patients as comparator.
Association of hospitalisation duration with culture-defined colonization by resistant Gram-negative bacilli, using non-invasive screening cultures and duration before sampling assessed at enrollment.
Microbiome and Disease
Association of culture-defined gut colonization by resistant Enterobacterales with subsequent bloodstream infection, using screening cultures and infection occurrence assessed during the same admission.
Association of vaginal microbiological profile with recurrent vulvovaginal symptoms, using routine culture and recurrence documented over six months.
Association of oral Candida colonization with recurrent oral lesions among diabetic adults, using non-invasive cultures and symptom recurrence documented over six months.
Association of skin Staphylococcus aureus carriage with recurrent skin infection among healthcare workers, using consented swabs and infection history documented over six months.
Association of respiratory colonization by resistant Gram-negative bacilli with subsequent pneumonia among high-risk inpatients, using screening cultures and infection occurrence during admission.
Association of culture-defined intestinal colonization with multidrug-resistant organisms and subsequent antibiotic use, using screening cultures and treatment records from the same admission.
Laboratory Methods and Diagnostic Microbiology
Microscopy
Diagnostic accuracy of direct Gram staining for significant bacteriuria among symptomatic adults, using quantitative urine culture as reference and sensitivity and specificity assessed at forty-eight hours.
Diagnostic accuracy of Gram staining of positive blood culture broth for bacterial category, using final culture identification as reference and concordance assessed at final reporting.
Diagnostic accuracy of sputum Gram staining for predominant bacterial pathogens, using culture as reference and performance assessed at forty-eight hours in acceptable-quality samples.
Inter-observer agreement in sputum Gram-stain quality scoring, using consensus microscopy as reference and kappa assessed before culture results are known.
Association of sputum microscopy quality score with bacterial culture yield, using final culture results and specimen-quality categories assessed during the same diagnostic episode.
Diagnostic accuracy of direct Gram staining of pus specimens for bacterial morphology, using culture identification as reference and sensitivity assessed at final reporting.
Association of inflammatory-cell abundance on pus Gram stain with culture positivity, using final bacterial culture as reference and diagnostic performance assessed at forty-eight hours.
Diagnostic accuracy of cerebrospinal fluid Gram staining for bacterial meningitis, using culture as reference and performance assessed at final microbiology reporting.
Diagnostic accuracy of direct microscopy of sterile body fluids for bacterial infection, using culture as reference and sensitivity assessed at final reporting.
Inter-observer agreement in Gram-stain interpretation of positive blood cultures, using final culture identification as reference and kappa assessed prospectively.
Diagnostic accuracy of Ziehl-Neelsen staining for pulmonary tuberculosis, using mycobacterial culture or cartridge-based nucleic acid amplification testing as reference and sensitivity assessed at final diagnosis.
Agreement between Ziehl-Neelsen and fluorescent staining for acid-fast bacilli in sputum, using cartridge-based nucleic acid amplification testing as reference and concordance assessed same day.
Comparative sensitivity of Ziehl-Neelsen and fluorescent microscopy among microbiologically confirmed pulmonary tuberculosis specimens, with bacillary grade compared on the same sample.
Inter-observer agreement in acid-fast bacillus smear grading, using expert consensus as reference and kappa assessed on routinely prepared sputum smears.
Association of acid-fast bacillus smear grade with cartridge-based nucleic acid amplification test semiquantitative category, using results from the same sputum specimen.
Association of acid-fast bacillus smear grade with time to positivity in mycobacterial culture, using sputum specimens and results assessed at final culture reporting.
Diagnostic accuracy of potassium hydroxide mount for superficial fungal infection, using fungal culture as reference and performance assessed at final culture reporting.
Agreement between potassium hydroxide mount and fungal culture in suspected dermatophytosis, with concordance assessed using samples collected during the same clinical visit.
Diagnostic accuracy of India ink microscopy for suspected cryptococcal meningitis, using cryptococcal antigen testing as reference and performance assessed during the same admission.
Agreement between India ink microscopy and cryptococcal antigen testing in cerebrospinal fluid, using culture where available and concordance assessed during the same episode.
Diagnostic accuracy of saline and iodine wet mounts for intestinal parasites, using concentration methods as reference and sensitivity assessed on the same stool specimen.
Agreement between direct wet mount and concentration methods for intestinal parasite detection, with concordance assessed on the same stool specimen.
Diagnostic accuracy of peripheral blood smear microscopy for malaria, using rapid antigen testing as comparator and species-level concordance assessed during the acute febrile episode.
Inter-observer agreement in malaria parasite species identification on peripheral smears, using expert consensus as reference and kappa assessed prospectively.
Inter-observer agreement in malaria parasite density estimation, using expert consensus counts as reference and reproducibility assessed on the same smear set.
Diagnostic accuracy of modified acid-fast staining for coccidian parasites in stool, using repeat microscopy or routine reference testing and performance assessed on the same episode.
Comparative yield of single and repeated stool microscopy for intestinal parasites, using cumulative detection as reference and incremental yield assessed within three days.
Diagnostic accuracy of Gram-stain morphology for preliminary identification of vaginal bacterial dysbiosis, using standardized microscopy scoring as reference and performance assessed same day.
Agreement between manual and digital microscopy image interpretation where available for selected routine stains, using expert review as reference and concordance assessed on the same slides.
Audit of microscopy reporting discrepancies corrected after senior review, using final verified reports as reference and discrepancy frequency assessed over six months.
Culture Methods
Diagnostic yield of repeat urine culture in initially contaminated midstream specimens, using final interpretable culture as outcome and additional diagnostic yield assessed within seventy-two hours.
Association of midstream urine specimen quality with culture contamination, using microscopy and collection documentation with contamination assessed at forty-eight hours.
Comparative recovery of urinary pathogens on chromogenic and conventional culture media, using final identification as reference and incremental yield assessed after overnight incubation.
Association of urine transport delay with bacterial colony counts, using promptly processed specimens as comparator and significant changes assessed at final culture reporting.
Comparative bacterial yield of direct plating and blood-culture bottle inoculation for sterile body fluids, with pathogen recovery and time to positivity assessed during routine processing.
Association of specimen volume with culture yield from sterile body fluids, using routine clinical specimens and positivity assessed at final culture reporting.
Diagnostic yield of anaerobic culture in clinically selected deep wound specimens, using aerobic culture as comparator and additional pathogen recovery assessed at final reporting.
Association of specimen type with anaerobic culture positivity among deep-seated infections, using routine anaerobic culture and organism distribution assessed at final reporting.
Comparative yield of swab and tissue specimens for culture in surgical site infection when both are clinically collected, using tissue culture as comparator and concordance assessed at forty-eight hours.
Association of pre-analytical transport delay with anaerobic culture positivity, using promptly transported specimens as comparator and recovery assessed at final reporting.
Diagnostic accuracy of potassium hydroxide microscopy against fungal culture in suspected dermatophytosis, with sensitivity and specificity assessed at final culture reporting.
Comparative yield of Sabouraud dextrose agar with and without antimicrobial supplementation for dermatophyte isolation, with recovery assessed at final fungal culture reporting.
Association of prior antifungal exposure with fungal culture negativity among suspected dermatophytosis, using untreated patients as comparator and exposure assessed before specimen collection.
Comparative culture yield from skin scrapings, nail clippings, and hair specimens in suspected dermatophytosis, with positivity assessed at final fungal culture reporting.
Species distribution and antifungal susceptibility of Candida bloodstream isolates, using routine culture identification and susceptibility testing with results assessed during the same admission.
Association of Candida species with intensive-care exposure among candidemia patients, using routine blood culture and ward location at culture positivity.
Association of candidemia with central venous catheter exposure, using culture-confirmed cases and matched culture-negative controls with device exposure assessed before blood culture.
Association of mycobacterial culture positivity with cartridge-based nucleic acid amplification testing among pulmonary tuberculosis specimens, with concordance assessed at final culture reporting.
Diagnostic yield of mycobacterial culture among cartridge-based nucleic acid amplification test-negative suspected tuberculosis specimens, with additional detection assessed at final culture reporting.
Association of sputum smear grade with mycobacterial culture time to positivity, using routine smear microscopy and automated culture results from the same specimen.
Comparative contamination rates of mycobacterial cultures from sputum processed on different working days, using routine culture records and contamination assessed at final reporting.
Association of sputum specimen quality with mycobacterial culture contamination, using collection characteristics and final culture status assessed after incubation.
Diagnostic yield of repeat mycobacterial culture after an initially contaminated specimen, with successful recovery assessed from the next clinically submitted specimen.
Association of specimen type with mycobacterial culture yield in extrapulmonary tuberculosis, using routine culture and positivity assessed at final reporting.
Comparative culture yield of blood specimens collected before and after empirical antibiotics when both are clinically obtained, with positivity assessed during the same sepsis episode.
Association of blood culture volume with pathogen recovery in adult sepsis, using recommended volume as comparator and positivity assessed during the same episode.
Association of number of blood culture sets with pathogen recovery, using single-set collection as comparator and incremental yield assessed during the same febrile episode.
Association of blood culture transport delay with positivity and time to detection, using automated culture and transport intervals recorded prospectively.
Comparative contamination rates of blood cultures collected in emergency and inpatient wards, using final clinical classification and rates assessed over six months.
Association of blood culture collection site with contamination, using peripheral and catheter-drawn cultures where clinically obtained and contamination assessed at final classification.
Automated Microbiology
Association of automated blood culture time to positivity with bacterial species among monomicrobial bloodstream infections, using final identification and time recorded during the same culture episode.
Association of automated blood culture time to positivity with contamination versus true bacteraemia, using clinical adjudication as reference and performance assessed at final classification.
Association of automated blood culture time to positivity with mortality among Gram-negative bacteraemia, using final culture identification and discharge outcome during the same admission.
Association of automated blood culture time to positivity with persistent bacteraemia among Staphylococcus aureus, using repeat culture positivity within seven days as outcome.
Comparative time to positivity of aerobic and anaerobic blood culture bottles in monomicrobial bacteraemia, using paired routine cultures and differences assessed during the same episode.
Association of bottle fill volume with automated blood culture time to positivity, using recorded volume and time-to-detection outcomes assessed prospectively.
Agreement between automated and conventional biochemical identification among Enterobacterales, with species concordance and turnaround time assessed at final reporting.
Agreement between automated and conventional identification among non-fermenting Gram-negative bacilli, with species concordance and turnaround time assessed prospectively.
Agreement between automated and conventional identification among Gram-positive cocci, with species concordance and turnaround time assessed at final reporting.
Frequency and causes of low-confidence automated bacterial identification, using repeat conventional testing as comparator and final resolution assessed within forty-eight hours.
Agreement between automated and disc diffusion susceptibility testing among Enterobacterales, using current Clinical and Laboratory Standards Institute breakpoints and categorical agreement assessed prospectively.
Agreement between automated and disc diffusion susceptibility testing among Pseudomonas aeruginosa, using current Clinical and Laboratory Standards Institute breakpoints and discrepancy rates assessed prospectively.
Agreement between automated and disc diffusion susceptibility testing among Staphylococcus aureus, using current Clinical and Laboratory Standards Institute criteria and categorical agreement assessed prospectively.
Agreement between automated susceptibility testing and broth microdilution for selected resistant Gram-negative isolates, with essential and categorical agreement assessed after confirmatory testing.
Frequency of major susceptibility discrepancies between automated and manual methods among multidrug-resistant isolates, with repeat reference testing used for final resolution.
Comparative turnaround time of automated and manual susceptibility testing for bloodstream isolates, with time from isolate availability to verified susceptibility report measured prospectively.
Association of automated susceptibility-system alerts with confirmed unusual resistance mechanisms, using phenotypic confirmatory tests and positive predictive value assessed after isolate characterization.
Frequency of susceptibility-report modification after manual review of automated results, using final verified reports and clinically significant changes assessed over six months.
Audit of automated microbiology instrument downtime and its effect on report turnaround time, using laboratory timestamps and delays assessed over six months.
Audit of repeat testing prompted by automated identification or susceptibility flags, using instrument records and final result changes assessed over six months.
Rapid Diagnostic Tests
Diagnostic accuracy of dengue rapid antigen testing in early febrile illness, using enzyme linked immunosorbent assay as reference and performance assessed by day of illness.
Diagnostic accuracy of malaria rapid antigen testing among febrile patients, using peripheral blood microscopy as reference and sensitivity and specificity assessed on the same specimen.
Diagnostic accuracy of cryptococcal antigen lateral-flow testing in cerebrospinal fluid, using culture or composite diagnosis as reference and performance assessed during admission.
Diagnostic accuracy of rapid hepatitis B surface antigen testing, using laboratory immunoassay as reference and performance assessed on the same serum specimen.
Diagnostic accuracy of rapid hepatitis C antibody testing, using laboratory immunoassay as reference and performance assessed on the same serum specimen.
Diagnostic accuracy of scrub typhus rapid antibody testing, using immunoglobulin M enzyme linked immunosorbent assay as reference and performance assessed during acute illness.
Diagnostic accuracy of leptospira rapid antibody testing, using immunoglobulin M enzyme linked immunosorbent assay as reference and performance assessed during acute illness.
Agreement between rapid and laboratory-based human immunodeficiency virus antibody tests, using the national testing algorithm as reference and concordance assessed during the same visit.
Diagnostic accuracy of cartridge-based nucleic acid amplification testing for pulmonary tuberculosis, using mycobacterial culture as reference and performance assessed at final culture reporting.
Diagnostic accuracy of cartridge-based nucleic acid amplification testing for extrapulmonary tuberculosis, using mycobacterial culture as reference and performance assessed at final reporting.
Agreement between cartridge-based nucleic acid amplification testing and smear microscopy in pulmonary tuberculosis, using culture as reference and concordance assessed on the same specimen.
Association of cartridge-based nucleic acid amplification test semiquantitative category with acid-fast smear grade, using paired results from the same sputum specimen.
Diagnostic yield of routine molecular testing in smear-negative pulmonary tuberculosis, using mycobacterial culture as comparator and additional detections assessed at final diagnosis.
Comparative turnaround time of molecular and conventional culture methods for tuberculosis, with time from specimen receipt to verified result measured prospectively.
Diagnostic yield of a routinely available syndromic respiratory panel compared with conventional microbiology among hospitalised patients, with additional pathogen detections assessed during admission.
Diagnostic yield of a routinely available meningitis syndromic panel compared with microscopy and culture, with additional detections assessed during the same admission.
Agreement between syndromic panel detections and conventional tests for bacterial pathogens, with concordance assessed during the same diagnostic episode.
Frequency of multiple-pathogen detections on syndromic panels, using conventional testing and clinical records to assess significance during the same episode.
Comparative turnaround time of syndromic panels and conventional microbiology, with time from specimen receipt to actionable verified result measured prospectively.
Audit of discordant rapid diagnostic test results and their resolution by reference testing, with final classification and reporting changes assessed over six months.
Laboratory Quality Assurance
Audit of internal quality-control failures in bacterial culture media, using departmental acceptance criteria and failure frequency assessed over six months: a laboratory-based quality-improvement study.
Association of culture-media batch age with internal quality-control failure, using routine control strains and acceptance outcomes assessed before clinical use.
Audit of antimicrobial susceptibility quality-control performance using standard reference strains, with out-of-range zone diameters and corrective actions assessed over six months.
Association of reagent lot changes with internal quality-control deviations in routine serology, using control values and out-of-range events assessed over six months.
Audit of daily temperature-monitoring compliance for microbiology refrigerators and incubators, using departmental standards and deviation frequency assessed over six months.
Association of incubator temperature deviations with culture quality-control failures, using monitoring logs and control-strain growth outcomes assessed during the same period.
Audit of external quality-assurance performance in bacteriology, using proficiency-testing scores and corrective-action completion assessed across available cycles over two years.
Audit of external quality-assurance performance in serology, using proficiency-testing results and corrective-action completion assessed across available cycles over two years.
Association of repeated external quality-assurance errors with test category, using proficiency records and error patterns assessed over two years.
Audit of corrective actions after external quality-assurance discordance, using documented laboratory procedures and closure of actions assessed within defined departmental timelines.
Verification of a newly introduced bacterial identification system using routine clinical isolates, with conventional identification as comparator and agreement assessed before routine implementation.
Verification of a newly introduced antimicrobial susceptibility platform using routine bacterial isolates, with reference manual methods as comparator and categorical agreement assessed before implementation.
Verification of a new lot of antimicrobial susceptibility discs using standard control strains, with zone diameters compared against accepted ranges before clinical use.
Verification of a new batch of culture media using standard control strains, with growth, inhibition, and colony characteristics assessed before release for clinical use.
Validation of a locally prepared chromogenic or differential medium against the routinely used commercial or standard medium, with organism recovery and identification agreement assessed before adoption.
Verification of a rapid antigen test using archived positive and negative clinical specimens, with the established laboratory assay as comparator and agreement assessed before routine use.
Audit of specimen rejection in a teaching hospital microbiology laboratory, using predefined rejection criteria and rejection rates categorized by specimen type over six months.
Association of specimen transport time with rejection or compromised quality, using laboratory timestamps and predefined acceptance criteria assessed prospectively over six months.
Audit of amended microbiology reports, using the original verified report as comparator and causes, frequency, and potential clinical significance assessed over twelve months.
Audit of microbiology laboratory turnaround time for urine, blood, respiratory, and sterile body fluid cultures, using predefined benchmarks and compliance assessed over six months.
Not the microbiology subspeciality you need? Basic and general microbiology is one section of our full microbiology collection — the hub page lists every subspeciality, each with its own free topic list. Updated September 2026.
📌 Updated for 2026–2027 MD and DNB Basic and General Microbiology admissions
The accompanying research guidance has been reviewed for laboratory feasibility, independent isolate selection, reference-method choice and reproducible resistance reporting.
Culture facilities, microscopy, validated identification procedures, susceptibility-testing materials and appropriate quality-control strains support many routine laboratory projects; confirm media, reagent supply and specimen volume before registration.
Whole-genome sequencing, MALDI-TOF and multiplex molecular platforms are not prerequisites for every project; questions about specific genes or genomic relatedness require the corresponding validated methods and funded access.
Publication potential lies in a clearly defined local evidence gap, reproducible assays and clinically interpretable findings, rather than a resistance percentage without a defensible denominator.
Generate a protocol from any topic above
Select Generate Protocol → beside any title in the list above and receive a submission-ready document built around that topic, containing all eighteen components:
Introduction / Synopsis
Research Question
Aim of the Study
Primary Objective
Secondary Objectives
Materials and Methods
Inclusion Criteria
Exclusion Criteria
Sample Size Calculation
Methodology
Statistical Analysis
Ethical Considerations
Review of Literature
References
Gantt Chart / Study Timeline
Patient Information Sheet
Consent Form
Data Collection Form
Already have your thesis title?
Generate the full basic and general microbiology protocol directly — objectives, methodology, sample size, statistics, timeline, references and annexures.
Alongside basic and general microbiology protocols and synopses, support is also available for departmental presentations, journal club presentations, ethics committee presentations, and posters and oral presentations for medical conferences — for postgraduate residents, board trainees and research scholars across India and the GCC. Prepared by a practising doctor with long experience in medical publishing and thesis supervision.
Basic and general microbiology research outside India
The topics above work as research questions anywhere — what changes is the document the institution expects, and who approves it before data collection begins. The Gulf equivalent of an Indian synopsis is the basic and general microbiology research proposal submitted to an institutional review board, and it ordinarily carries three sections an Indian synopsis does not: a Gantt chart, a budget and resources section, and a Declaration of Helsinki statement.
Board and residency programmes — country by country
Saudi Arabia — SCFHS and the Saudi Board. Residency and fellowship training under the Saudi Commission for Health Specialties includes a research project with a set timeline, and the basic and general microbiology research proposal is the document prepared at the outset and cleared by the institutional review board before recruitment starts.
United Arab Emirates — DHA, DOH Abu Dhabi and MOHAP. Residents training in Dubai, Abu Dhabi and the northern emirates prepare a basic and general microbiology research protocol for their programme and submit it for institutional review board approval before any data are collected.
Qatar — DHP (formerly QCHP) and Hamad Medical Corporation. A basic and general microbiology IRB proposal is reviewed before recruitment, with the ethics section written to the institution's own template rather than a generic one.
Bahrain — NHRA. Trainees turning basic and general microbiology research topics into a project need the proposal cleared by their institutional research and ethics committee before fieldwork begins.
Oman — OMSB. Residency programmes under the Oman Medical Specialty Board include a research component, and the basic and general microbiology research proposal is the document assessed at the start of it.
Kuwait — KIMS. A basic and general microbiology study protocol goes to the institutional committee for approval before the project begins.
Arab Board programmes across the region. The Arab Board carries its own research requirement irrespective of the host country, and the basic and general microbiology proposal follows the same structure throughout.
Postgraduate degrees — Malaysia, the Gulf and beyond
Malaysia — MMed, the National Medical Research Register and MREC. A basic and general microbiology dissertation proposal for a Master of Medicine programme carried out in a Ministry of Health facility must be registered on the NMRR and approved by the Medical Research and Ethics Committee before the study begins, and the guidance asks for submission four to six months ahead of data collection. Every investigator on the study team registers on the NMRR as well, so the methodology, ethics and team sections are written in far more detail than an Indian synopsis requires.
PhD and Master's candidates elsewhere. University programmes generally require a full basic and general microbiology research proposal of roughly 6,000 to 10,000 words, with an extended literature review, a theoretical framework and a detailed methodology chapter.
PhD and MMed proposals are written individually by a medical doctor and revised until the supervisor accepts them. They are not produced by the automated protocol generator.
🔥 Trending research areas in Basic and General Microbiology for 2026–27
Rapid phenotypic susceptibility testing: evaluating earlier actionable results from positive blood cultures, with method-specific reading times, interpretive criteria and conventional comparators.
Phenotype and genotype discordance: investigating why a resistance phenotype and a targeted molecular panel disagree, while recognising that a panel detects only the targets it includes.
Digital microscopy and assisted identification: assessing local performance on independently labelled images, with training and evaluation separated by patient or isolate to prevent data leakage.
Reproducibility of biofilm measurements: testing how inoculum, medium, incubation and plate batches affect assay results before relating laboratory biofilm production to clinical characteristics.
Protocol and synopsis guidance
What a Basic and General Microbiology protocol must contain
Define the biological unit. State whether the primary analysis concerns patients, infection episodes, specimens or unique isolates. Specify specimen acceptance criteria, organism identification, handling of mixed growth and the rule for repeat isolates from the same patient. Keep colonisation, contamination and clinically adjudicated infection distinct when clinical interpretation is an objective.
Make the laboratory workflow reproducible. Record transport conditions, processing delays, identification criteria, inoculum preparation, media, incubation, controls, replicate handling and invalid-result rules. For susceptibility studies, name the interpretive standard and edition, retain raw zone diameters or MICs and predefine how breakpoint changes during recruitment will be handled. Do not combine categories generated under different systems without a justified harmonisation plan.
Match the claim to the method. A screening phenotype does not identify a particular resistance gene. Choose a justified reference method, blind interpretation where possible and apply the planned comparator consistently rather than only to discordant specimens. For biofilm assays, distinguish independent isolates from repeated wells and standardise the blank correction and classification threshold.
Basic and General Microbiology synopsis versus Basic and General Microbiology protocol
The synopsis presents the research question, rationale, objectives, design, sample-size basis and essential methods in the university's required format. The protocol supplies the operational detail needed to conduct that study consistently; institutional terminology may overlap.
In this subject, even a short synopsis must identify the isolate-selection rule, principal laboratory endpoint and comparator. The full protocol should additionally explain isolate storage and revival, failed cultures, mixed isolates, batch controls, repeat testing and unavailable molecular results. Preserve separate definitions for phenotypic resistance, detection of a named gene and clinical infection throughout both documents.
Sample size and statistical analysis
Calculate for the primary endpoint. A resistance-proportion study needs an expected proportion, confidence level and absolute precision. An accuracy study needs adequate reference-positive and reference-negative isolates for its intended sensitivity and specificity precision. A comparison of biofilm measurements needs an anticipated difference and variability at the independent-isolate level.
Avoid artificial sample inflation. Three wells containing the same isolate are technical replicates, not three independent observations. Summarise them within isolate or use a justified hierarchical model. Account for repeated patients or episodes if these remain in the dataset, and allow for contamination, non-viable stored isolates and incomplete reference testing.
Separate agreement from accuracy. Report paired results and confidence intervals. Use agreement measures for method concordance; sensitivity and specificity require a defensible reference classification. In AST comparisons, specify categorical and essential agreement where applicable, with explicit denominators for false-susceptible and false-resistant errors. In association analyses, consider species, specimen source, ward and prior antimicrobial exposure rather than attributing every difference to biofilm production.
Frequently Asked Questions – BASIC AND GENERAL MICROBIOLOGY Thesis Topics (2026–27)
1. How do I choose a feasible Basic and General Microbiology thesis topic?
For the 2026–2027 admission cohort, start with recent laboratory workload, the expected number of unique eligible isolates and a question that existing methods can answer. Check turnaround time, reagent costs, control strains and guide expertise. Prefer one primary outcome with a reliable denominator over several advanced assays whose availability is uncertain.
2. Which study designs can be used for Basic and General Microbiology research?
Depending on the question and institutional requirements, suitable designs include cross-sectional isolate surveys, analytical observational studies, diagnostic-accuracy evaluations, paired method comparisons and controlled laboratory experiments. A project following patients for subsequent outcomes is longitudinal; an experiment changing culture conditions is not a clinical cross-sectional study. Confirm acceptance with the university or training board.
3. What should I settle with my guide before finalising the title?
Agree on the organism group, specimen sources, primary endpoint, independent unit, repeat-isolate rule, reference method, assay platform and total cost. Confirm access to clinical variables, permission to retrieve stored isolates, biosafety arrangements and a realistic recruitment estimate. The wording of the title should reflect the tests actually available, especially when claiming molecular characterisation.
4. Can I use stored isolates or retrospective laboratory records?
Yes, if permissions, ethics review and data quality support the question. Audit storage conditions, revival success, identification reliability, raw susceptibility measurements and patient identifiers needed for deduplication. Selective retention of unusual or resistant isolates can distort prevalence estimates. If original zone diameters or MICs are unavailable, historical susceptibility categories may not be reclassifiable under a different breakpoint edition.
5. Is a Basic and General Microbiology synopsis the same as a protocol?
The synopsis is usually the submission document summarising the proposed study, while the protocol gives the detailed plan for its conduct. Some institutions use the terms interchangeably. Both must agree on objectives, isolate eligibility, sample size, laboratory methods, analysis and ethics; follow the prescribed institutional format.
6. What ethical safeguards are needed for a Basic and General Microbiology study?
Obtain Institutional Ethics Committee review before research access or collection. Record-based work and residual specimens need an approved consent waiver where justified, not an assumed exemption. Prospective participation requires consent; for children, obtain guardian permission and age-appropriate assent from about seven years, as applicable. A residual-specimen design should add no radiation, contrast or research-only venepuncture; state additional research blood volume as 0 mL. If extra blood is essential, justify a numerical volume and frequency limit for the population and obtain approval. Seek separate consent for identifiable photographs or video.
Use coded laboratory records and controlled access. Predefine a pathway from the investigator to the consultant microbiologist, treating clinician and infection-control team for unexpected clinically significant resistance or suspected clusters; validate research findings before clinical use. These safeguards should be aligned with ICMR ethical guidance.
7. Can I count every positive culture as an independent isolate?
No. Serial cultures from one patient can repeatedly sample the same organism, and prolonged admissions may contribute disproportionately resistant isolates. Define a rule appropriate to the question, such as the first eligible isolate of a species per patient within a prespecified period, with explicit handling of new episodes and different specimen sites. Report the selection flow and denominator. If repeat isolates are the object of study, retain them with patient linkage and an analysis that accounts for within-patient correlation.
8. Can these topics support a PhD proposal or a Gulf board research project?
They can provide a starting point, but a PhD proposal requires a defensible original contribution and depth beyond the usual MD synopsis. For SCFHS and Saudi Board programmes, the Arab Board of Health Specializations, and DHP-, DHA-, DOH- or MOHAP-linked training programmes, map the question to the specific curriculum, supervisor requirements and local ethics process. Where a board research project is mandatory, confirm its required scope and assessment format. Do not assume that all regulators or linked programmes impose the same research requirement or accept an Indian dissertation format.
9. When should I register my Basic and General Microbiology thesis topic?
Register within the deadline specified by the university or training board after agreement with the guide and a feasibility review. Obtain the required scientific, departmental and ethics approvals before recruitment, research testing or research access to identifiable records. Leave enough time for seasonal variation where relevant, isolate processing, repeat assays, analysis and dissertation submission.
Found a topic that fits your department?
Generate its full protocol — objectives, methodology, sample size, statistics, timeline, references and annexures — in editable format.